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Summary
The Nobel prize winning discovery of the human glucocorticoid (GC), cortisol, was
instrumental in steroidal anti-inflammatory medication development. GCs are em-
ployed to combat diseases caused by malfunctions in the immune response such
as rheumatoid arthritis, allergies, asthma, sepsis, acute transplant rejection and
graft-versus-host disease. However, as with many members of the steroid class,
GCs regulate a plethora of biological processes and consequently therapeutic use is
associated with a number a side effects.
The majority of GC effects are mediated through activation of their cognate
steroid receptor, the glucocorticoid receptor (GR). In the inactive form, the GR
resides in the cytoplasm as a monomer. Upon ligand binding the receptor-ligand
complex translocates into the nucleus. Once inside the nucleus, the GR can ei-
ther remain a monomer and act as a trans-acting transcriptional repressor, which
is associated with the positive effects of GC treatments. Alternatively, the GR can
dimerise and act as a cis-acting transcriptional activator, associated with the side
effects of GC treatments. Therefore, ligand binding and dimerisation are major fac-
tors that determine GC signal transduction and subsequent induction or repression
of transcription.
Ligand activation of GR can follow two pathways, which occur simultaneously:
either via the “classical pathway”, which consists of ligand binding to monomeric
GR, which subsequently dimerises, or via the “alternative pathway”, where GR
dimerises independently of ligand and ligand subsequently binds to the dimer.
Being hydrophobic, GCs are able to pass through the cell membrane without
transporters, hence, at any given time, their cellular concentration is roughly equal
in most tissues. Conversely, GRs are present throughout the body at different
concentrations depending on tissue type, inter individual variation, physiological
conditions and disease state. Taken together, GR level is likely a primary cause of
variations in GC activity.
Until recently, the influence of GR concentration on GC activity had not been
quantified nor had the molecular mechanism been elucidated. In 2013, Robertson et
ii
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al. showed that the Hill coefficient and potency of GR-Dexamethasone (Dex) bind-
ing increased with an increase in GR concentration. The shifts in Hill coefficient
and potency were abolished when dimerisation was abrogated using a dimerisation
deficient mutant. The same study showed that high levels of wild type GR displayed
ligand-independent dimerisation, which is a prerequisite for cooperative ligand bind-
ing.
A major outcome of this project was the formulation of a mathematical model of
the GR dimerisation cycle and Dex binding. Significantly, this model captured GR
concentration-dependent shifts in potency and Hill coefficient when simulating GR-
Dex saturation binding experiments, albeit not to the same extent as experimental
data from literature. This correlates with the increase in potency and Hill coefficient
with an increase in GR concentration shown by Robertson et al..
Furthermore, this model is capable of simultaneously predicting GR-GC binding
in cells with different GR concentrations, which more closely resembles a transiently
transfected cell population. Using a method developed in this study, the specific
binding of a population of cells can be scaled to the relative distribution of GR
within that cell population.
The kinetic basis for the increase in potency was determined in this study as
a GR concentration-dependent decrease in koff as kon remained constant. This de-
crease in koff was eliminated when dimerisation was abrogated and therefore the
concentration-dependent shift in potency is most likely attributed to the dimerisa-
tion reactions present in both the classical and alternate pathways of GR activation.
This project comprised a novel approach of simulating GR-GC binding, consid-
ered a requisite step of GR activation. The findings demonstrate that the GC signal
transduction system is more sensitive to GR concentration than has been previously
anticipated. This has implications for GC signal transduction research, steroid re-
search in general, as well as for therapeutic regimes and the development of GC
resistance.
iii
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Opsomming
Die ontdekking van die menslike glukokortiko¨ıed (GC) kortisol, wat met die Nobel-
prys bekroon is, het ’n belangrike bydrae gelewer tot die ontwikkeling van stero¨ıedale
anti-inflammatoriese medikasie. GCs word gebruik om siektes wat deur gebreke in
die immuunstelsel veroorsaak word, soos rumato¨ıede artritis, allergiee¨, asma, sepsis,
akute oorplanting verwerping en ent-versus-gasheer siekte, te behandel. Soos met
baie lede van die stero¨ıed-klas van molekule, reguleer GCs egter ’n wye reeks van
biologiese prosesse, en om hierdie rede gaan terapeutiese gebruik dikwels gepaard
met ’n aantal newe-effekte.
Die meerderheid van die GC-effekte word bemiddel deur aktivering van die
glukokortiko¨ıed-reseptor (GR). Die onaktiewe vorm van GR kom in die sitoplasma
voor as ’n monomeer en beweeg na die selkern wanneer dit aan ’n gepaste stero¨ıed
bind. Sodra die GR binne die selkern is kan dit as monomeer as ’n transkripsionele
onderdrukker optree, wat geassosieer word met die positiewe effekte van GC be-
handeling. Alternatiewelik kan die GR optree as ‘n dimeer, in hierdie geval as ’n
transkripsiefaktor deur te bind aan GC responselemente om gene te aktiveer. Hierdie
meganisme van werking word geassosieer met die newe-effekte van GC behandeling.
Dus bepaal ligandbinding en reseptor-dimerisering die seintransduksie van GCs en
die daaropvolgende induksie of repressie van transkripsie.
Die aktivering van GR deur ligandbinding kan twee wee¨ volg wat gelyktydig
plaasvind: in die “klassieke pad” bind die ligand eers aan monomeriese GR wat later
dimeriseer, terwyl GR in die “alternatiewe pad” ’n dimeer vorm in die afwesigheid
van ligand, waaraan die ligand daarna bind.
Omdat GCs hidrofobies is, is dit in staat om sonder transportprote¨ıene deur die
selmembraan te beweeg, dus is hul selluleˆre konsentrasie min of meer gelyk in die
meeste weefsels. Aan die ander kant is GRs teenwoordig in verskillende konsentrasies
in die liggaam, afhangende van die tipe weefsel, variasie tussen individue, fisiologiese
toestande en siektes. Met hierdie punte in gedagte kan daar afgelei word dat die
GR waarskynlik die belangrikste bydraende faktor is wat differensie¨le GC aktiwiteit
bepaal.
iv
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Tot onlangs was die invloed van GR konsentrasie op GC aktiwiteit, asook die
molekuleˆre meganisme hiervan, nie bepaal nie. In 2013 het Robertson et al. getoon
dat die Hill koe¨ffisie¨nt van GR-dexametasoon binding asook die potensie toegeneem
het wanneer die totale GR konsentrasie verhoog word. Dieselfde studie het gewys
dat hoe¨ vlakke van wilde-tipe GR ligand-onafhanklike dimerisering kan toon, ’n
voorvereiste vir koo¨peratiewe ligandbinding. Ten slotte kon die verskuiwings in
Hill koe¨ffisie¨nt, potensie en ligand-onafhanklike dimerisering opgehef word deur die
gebruik van ’n GRdim mutant wat nie tot dimerisering in staat is nie.
’n Kern uitkoms van hierdie projek was die formulering van ’n wiskundige
model van GR dimerisering en Dex binding. Hierdie model kon die eksperimenteel
waargenome skuiwe in potensie en Hill koe¨ffisie¨nt met verandering in GR kon-
sentrasie naboots, wanneer Dex-GR versadigings-bindingseksperimente gesimuleer
word, al was die grootte van hierdie verskuiwings nie dieselfde as in eksperimentele
data uit die literatuur nie. Hierdie studie bevestig dus die toename in potensie en
Hill koe¨ffisie¨nt met ’n toename in GR konsentrasie, wat oorspronklik deur Robertson
et al. is aangetoon.
Verder is hierdie model in staat om GR-GC binding te voorspel in selle met ver-
skillende GR konsentrasies. Daar word berig oor die ontwikkeling van ’n metode om
die spesifieke binding in ’n populasie van selle te skaleer tot die relatiewe verspreiding
van GR binne daardie populasie.
Die onderliggende kinetiese grondslag vir die toename in potensie is in hierdie
studie bepaal, nl. ’n GR konsentrasie-afhanklike afname in koff terwyl kon min of
meer konstant bly. Hierdie afname in koff word gee¨limineer wanneer dimerisering
uitgeskakel word, en derhalwe kan die konsentrasie-afhanklike verskuiwing in poten-
sie waarskynlik toegeskryf word aan die dimeriseringsreaksies in beide die klassieke
en alternatiewe roetes van GR aktivering.
Hierdie projek behels ’n nuwe benadering tot die simulering van GR-GC binding,
wat beskou word as ’n noodsaaklike stap in GR aktivering. Die bevindinge toon dat
die GC seintransduksie-stelsel meer gevoelig is vir veranderinge in GR konsentrasie
as wat voorheen verwag was. Dit het implikasies vir navorsing oor GC seintrans-
duksie, stero¨ıede in die algemeen, asook vir stero¨ıed-terapiee¨ en die ontwikkeling van
weerstand teen GCs.
v
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Chapter 1
Project motivation and outline
Steroids and their cognate receptors mediate a plethora of biological processes in
the human body. Glucocorticoids (GCs) regulate the immune, cardiovascular and
metabolic systems, to name a few, and have been exploited as inflammation sup-
pressors for over 60 years. GCs mediate the majority of their effects through the
glucocorticoid receptor (GR) and while this field of signal transduction has been
studied for many years, it still regularly yields novel findings. Furthermore, there is
no indication that this will cease and with the proliferation of computational tech-
niques, more aspects of the GC signal transduction system are becoming available
for study. While there are many mechanisms of action employed by the GC/GR
system, this thesis focuses specifically on its classical role of a signal transduction
mechanism.
The GR-GC signal transduction system is a therapeutic target, which has the
potential to vastly improve the quality of life of many patients. However, there are
still a number of gaps in our understanding that limit our ability to use this system to
its fullest capacity. Taking into account that GC activity varies between tissues, GC
concentration is relatively equal throughout the body at a specific time. Since GCs
exert much of their effects through the GR and that GR concentration varies between
tissues, it seems likely that GR concentration is a major factor that determines GC
activity. For example, a study has shown that increasing GR concentration from
67.0 to 283.9 fmol GR/mg protein increases the potency of Dexamethasone (Dex)
via the GR 2600-fold and that this concentration-dependent increase in potency is
eliminated when dimerisation of the GR protein was abrogated1. For this reason, re-
search into GR dimerisation could elucidate the mechanism underlying the difference
in GC activity between tissues and disease states. Specifically, this project focused
on producing a mathematical model capable of predicting liganded and unliganded
GR monomer and dimer species concentrations over a range of GR concentrations
1
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2during Dex stimulation.
Attainment of this goal required a number of incremental aims to be achieved.
First, the mathematical framework of the model was formulated based on the reac-
tion scheme shown in Figure 2.8. Second, the model was populated with kinetic
parameters such that it was able to replicate experimental data. Furthermore, these
kinetic parameters were determined using a combination of existing experimental
data and newly generated experimental data when necessary. Finally, the model
was used to simulate ligand binding to GR under different conditions to examine
the behavior of this system.
Briefly, the remainder of the thesis is organized as follows:
Chapter 2 serves as a summary of the literature relevant to this project. Succeed-
ing chapters draw heavily on the information on glucocorticoids, the glucocorticoid
receptor and modelling signal transduction mechanisms presented in this chapter.
In Chapter 3, the results of the in vitro and in silico experiments performed in
the course of this study are presented. These entail the details of the formulation of
a mathematical model of the GR dimerisation cycle, the processes used to determine
the parameters of this model, a whole cell binding time course, a transfection time
course and the formulation of a compartmental model of the GR dimerisation cycle.
In Chapter 4, the broader context of the results of this study are discussed
including the limitations encountered in this project as well as potential future
work.
Finally, in Chapter 5, the techniques used in this project are described in suffi-
cient detail for replication. This entails descriptions of in vitro and in silico experi-
mental protocols as well as the details of reagent procurement.
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Chapter 2
Introduction to glucocorticoids,
the glucocorticoid receptor and
nuclear receptor modelling
2.1 Glucocorticoids
Steroids are a group of organic molecules found in many species across the prokary-
otic and eukaryotic kingdoms. Their primary functions in eukaryotes are signal
transduction and cellular membrane fluidity regulation. Steroids contain a distinc-
tive 17-carbon atom, 4-ring structure, called a gonane, shown in Figure 2.1 (A).
Figure 2.1 (B) shows the prototypical animal steroid, cholesterol, from which all
other steroids are derived. In animals, there are 5 classes of steroids: estrogens,
androgens, progesterones, mineralocorticoids and GCs.
The name “glucocorticoid” is derived from the role of these steroids in glucose
metabolism (gluco), their production location in the adrenal cortex (corti) and their
steroidal (oid) structure. Since the Nobel Prize winning discovery of cortisol, shown
in Figure 2.1 (C), by Edward Kendall and Harold Mason2,3, GCs have been used
to treat rheumatoid arthritis as well as other rheumatological and inflammatory
conditions. Exogenous GCs, such as cortisone or Dex, cause an upregulation in anti-
inflammatory proteins and a downregulation in pro-inflammatory proteins. Unlike
androgens and estrogens, GCs are not particularly associated with one of the sexes
and are found throughout the human body.
3
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A
B
C
Figure 2.1: Steroid structure. (A) gonane, the nucleus of steroid
molecules. (B) cholesterol, the prototypical animal steroid. (C)
cortisol, the classical glucocorticoid.
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2.1. GLUCOCORTICOIDS 5
2.1.1 Biosynthesis
GCs are produced in the zona fasciculata of the adrenal cortex in the adrenal gland,
as shown in Figure 2.2, and transported to tissues throughout the body via the cir-
culatory system. Cortisol is synthesized after cholesterol undergoes side chain cleav-
age by the Cytochrome P450 cholesterol side chain cleavage enzyme (CYP11A1),
17α-hydroxylation by the Cytochrome P450 17α-hydroxylase/17,-20-lyase enzyme
(CYP17A1), oxidation by the 3-beta-hydroxysteroid dehydrogenase enzyme (3β-
HSD), 21-hydroxylation by the Cytochrome P450 steroid 21-hydroxylase enzyme
(CYP21A2) and 11β-hydroxylation by the Cytochrome P450 11β-hydroxylase en-
zyme (CYP11B1) shown in Figure 2.3. Being hydrophobic, GCs are able to pass
through the cell membrane without transporters, therefore their cellular concentra-
tion is approximately equal at any given time in most tissues with adaquate access
to the blood system.
Figure 2.2: The adrenal gland and a cross-section of its subdivi-
sions. The adrenal gland is located above the kidney. It contains
the medulla, capsule and the andrenal cortex. The adrenal cortex
is partitioned into three zones, notably the zona fasciculata where
glucocorticoids are produced. Reproduced from Michigan Surgerya.
ahttp://michigansurgery.com/general-surgery/adrenal-gland/
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2.1. GLUCOCORTICOIDS 6
Figure 2.3: The biosynthetic pathways of two glucocorticoids:
cortisol and corticosterone. Cortisol is synthesized after choles-
terol undergoes side chain cleavage by Cytochrome P450 cholesterol
side chain cleavage (CYP11A1), 17α-hydroxylation by Cytochrome
P450 17α-hydroxylase/17,-20-lyase (CYP17A1), oxidation by 3-
beta-hydroxysteroid dehydrogenase (3β-HSD), 21-hydroxylation by
Cytochrome P450 steroid 21-hydroxylase (CYP21A2) and 11β-
hydroxylation by Cytochrome P450 11β-hydroxylase (CYP11B1).
ER, endoplasmic reticulum; StAR, Steroidogenic acute regulatory
protein. Reproduced from Point Institutea.
ahttp://www.pointinstitute.org/category/blog/
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2.1.2 Regulation of glucocorticoid levels
HPA axis
GCs are the primary mediators of the stress response via the hypothala-
mic–pituitary–adrenal axis (HPA)4. The HPA includes the hypothalamus, pituitary
and adrenal glands and is regulated by negative feedback mechanisms by cortisol as
shown in Figure 2.4. The hypothalamus acts as an interpreter by converting neural
stimuli into a hormonal signal. Hormonal signals have the advantage over neural
signals in that they are delivered to the entire body over a longer period of time5.
The HPA plays a critical role in regulating the immune response to effectively deal
with threats as well as to limit autoimmune harm from inflammatory responses6–8.
Figure 2.4: The hypothalamic–pituitary–adrenal axis consists of
the hypothalamus, the pituitary and adrenal glands. The hypotha-
lamus produces corticotrophin releasing hormone (CRH). CRH
stimulates the pituitary to produce adrenocorticotrophic hormone
(ACTH). ACTH stimulates the adrenal gland to produce glucocor-
ticoids, which, in turn, inhibit the hypothalamus and pituitary to
produce less CRH and ACTH respectively, thereby forming a neg-
ative feedback loop. Reproduced from Adrenal Fatigue Solutiona.
ahttps://adrenalfatiguesolution.com/hpa-axis/
Cortisol production is initiated when neurons in the hypothalamus are stimu-
lated to produce corticotrophin releasing hormone (CRH)9. This CRH travels to
the anterior pituitary via the hypophyseal portal system and stimulates the release
of adrenocorticotrophic hormone10 (ACTH). CRH mediated release of ACTH is re-
sponsible for the diurnal rythm of cortisol levels as well as responses to psychiatric
disturbances, adrenergic agonists, interleukins and other stresses. ACTH travels via
the bloodstream to the adrenal gland where it stimulates the production of GCs in
the zona fasciculata via activation of melanocortin receptor 211,12. Both ACTH and
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CRH production are under negative feedback by circulating cortisol13.
Plasma circulation
Circulating cortisol is distributed in various forms with 80-90% bound to corticos-
teroid binding globulin14,15 (CBG), 5-10% bound to albumin15 and 3-10% free15,
biologically active cortisol16. The level of free cortisol is regulated by negative feed-
back of glucocorticoids within the HPA. Accordingly, when the level of CBG or
albumin is increased or decreased, resulting in either lower or higher plasma cortisol
levels, ACTH levels are increased or decreased, which up- or downregulates cortisol
production and restores plasma levels.
2.1.3 Mechanism of action and modes of DNA binding
The classical explanation of GC-GR activity is shown in Figure 2.5. Initially,
the unliganded GR resides in the cytoplasm as a monomer. When ligand enters
the cytoplasm, it binds to the GR and this complex trans-locates into the nucleus.
Once inside the nucleus, the GR remains a monomer and acts as a transcriptional
repressor by tethering to the transcription factors associated with the promotors
of other genes; this transrepression is associated with the positive effects of GC
treatments. Alternatively, the GR dimerises and acts as a transcription factor by
binding to GC response elements (GRE) and activating genes; this transactivation
is associated with the negative side effects of GC treatments17,18. The GR-GRE
complex recruits co-factors such as histoneacetyltransferases, which open the chro-
matin structure. This causes upregulation of transcription, usually within a few
hours after GC exposure19.
However, the range of GR activation mechanisms has been greatly expanded
to include liganded GR homodimers binding to negative GREs (nGRE) either up-
stream or downstream of the transcription start site, resulting in downregulation
of transcription20–22. The consensus sequence of nGREs differs from that of GREs
and, upon GR binding, results in the recruitment of co-repressors, such as nuclear
receptor co-repressor 1 and 2, instead of co-activators23. Additionally, liganded
monomeric GR has been shown to tether to other DNA interacting transcription
factors and thereby upregulate the genes they control24,25 as well as to occupy
monomeric-binding sites and drive transcription26,27.
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Figure 2.5: Classical activation of the glucocorticoid receptor
(GR). The classical explanation of glucocorticoid (GC) GR activity
is that the GR resides in the cytoplasm as a monomer. When ligand
is added, it binds to the GR and this complex trans-locates into the
nucleus. The GR now can either dimerise and act as a transcrip-
tion factor binding to glucocorticoid response element (GRE) and
activating genes or it remains a monomer and acts as a transcrip-
tional repressor by binding to the transcription factors associated
with the promoters of other genes. HSP, Heat shock protein; GRα,
Glucocorticoid Receptor subtype-alpha; TF, transcription factor;
TFRE, transcription factor response element.
Reproduced from Brain Immunea.
ahttp://brainimmune.com/the-glucocorticoid-receptor/
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2.1.4 Biological effects
The effects of GCs are classified primarily as either immunological or metabolic
but a significant number of effects also involve development and homeostasis. The
majority of effects of GCs studied to date are mediated through interaction with
the GR, usually leading to regulation of transcription.
Metabolic effects
The role of cortisol and hydroxycortisol in glucose metabolism was discovered shortly
after their inflammation suppressing qualities28–31. In many respects GCs play an
antagonistic role to insulin in glucose metabolism and maintain or increase blood
glucose levels. High GC levels result in insulin resistance-like symptoms such as
up-regulation of hepatic gluconeogenesis and reduced peripheral glucose uptake32.
In early fasting, GCs stimulate gluconeogenesis by upregulation of phospho-
enolpyruvate carboxykinase, an enzyme in gluconeogenesis, particularly in the liver,
resulting in non-hexose production of glucose33. In late fasting, GCs stimulate glyco-
genesis in preparation for starvation. Under conditions that lead to high insulin
levels, such as while recovering from stress, glycogen accumulation is promoted by
GCs34. Additionally, GCs reduce blood flow and therefore reduce glucose mobility
and delivery in the body35. The effects of GCs have the effect of amplifying the
response to other metabolic regulation stimuli36.
GCs also stimulate extrahepatic amino acid mobilization, inhibit muscular and
adipose tissue glucose uptake as well as stimulating lipolysis in adipose tissue34,37,38.
In vitro studies show that GCs induce adipocytes to release free fatty acids39. In
cells activated by growth hormone, GCs increase the lipolysis stimulation caused by
catecholamines. However, in the presence of insulin, GCs reduce the basal lipoly-
tic rate and responsiveness to catecholamines40. Therefore, in adipose tissue, the
uptake and turnover of fatty acids as well as response to stimuli such as insulin
or catecholamines are modulated by GCs, similar to their role in glucose/glycogen
metabolism.
Immunological effects
Overall, GCs act as immunosuppressants by regulating a number of specific lym-
phocyte processes. GCs regulate T-lymphocyte homeostasis and development41,
inhibition of T-lymphocyte migration to inflammatory sites and the enhancement of
scavenger mechanisms leading to the cleanup of microorganisms, dead cell bodies and
antigens42,43. In addition, many inflammatory cytokines, such as interleukin (IL)-
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1β, tumor necrosis factor (TNF)α, IL-6, IL-8, IL-12 and IL-18, are downregualted
by GCs while anti-inflammatory cytokines, such as IL-10 and transforming growth
factor-β44–47, are upregulated. T-cells constantly produce “survival signals” that
allow peptide or major histocompatibility complex recognition by T-cell receptors
to avoid the induction of apoptosis41. Apoptosis is the major mechanism of T-cell
removal and these survival signals are downregulated by GCs.
GCs regulate the immune system primarily through apoptosis, however the gov-
erning mechanisms are not completely understood and vary with cell type. GCs
activate apotosis in a number of cell types through the Bcl-2 protein family by upreg-
ulation of the pro-apoptotic members, Bim, Bid and Bad48–50, and downregulation
of the anti-apoptotic members, Bcl-2, Mcl-1 and Bcl-xL50–52. GCs stimulate phos-
phatidylinositol 3-kinase and the protein kinase AKT53, which cause rapid changes
in the cytoplasmic environment leading to endothelial nitric oxide synthase acti-
vation and nitric oxide-dependent vasorelaxation54. Additionally, GC induced GR
translocation has been observed in GC responsive cells and not GC resistant cells,
indicating that GCs influence apoptosis through the mitochondrial pathway55,56.
Cognitive effects
Patients using GC medication or suffering from Cushing’s syndrome, discussed in
Section 2.1.5, frequently suffer from impaired attention, concentration and mem-
ory57–60. The cognitive effects of GCs are effected by their action on the hippocam-
pus, amygdala and frontal lobes. Long term memory potentiation is optimal at
mildly elevated GC levels and inhibited at low or high GC levels61. Memory recol-
lection is impaired during times of mildly raised GC levels. During an emotionally
stressful event, GCs enhance flashbulb memory formation related to that event and
inhibit memory formation of details not related to the event62.
2.1.5 Role in modern medicine
There are 44 million prescriptions for GCs in the US annually63 and long term pre-
scription in the UK has increased by 34% in the last 20 years64. GCs are the primary
treatment for an array of medical conditions, primarily as an anti-inflammatory drug.
The wide spread use of GCs has led to the development of many synthetic variations,
such as Dex described below. However, endogenous GCs regulate a number of other
biological processes besides inflammation and therefore GC therapies are linked to
many side effects as well as the development of GC resistance.
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Anti-inflammatory drugs
GCs are employed pharmacologically to combat diseases brought about by the im-
mune system such as rheumatoid arthritis, allergies, asthma, sepsis, acute transplant
rejection and graft-versus-host disease. Sepsis, an autoimmune condition brought
about by infection65, is estimated to be responsible for 60% of deaths in the devel-
oping world∗. GCs are prescribed as pills or as topical applications such as creams,
nasal sprays and inhalers owing to the reduced side effect profile of these formula-
tions. The anti-inflammatory effects of GCs are elicited through a number of mecha-
nisms and at different levels. GC activated GR induces upregulation of the annexin 1
protein, which inhibits the activity of phospholipase A2α, an enzyme involved in in-
flammation via the production of the pro-inflammatory prostaglandins. TNFα, a
cytokine involved in acute inflammatory response, has an unstable mRNA, which is
stabilized when cells are stimulated by proinflammatory signals66. GCs negate this
stabilization by stimulating proteins, such as tristetraprolin, which promote degra-
dation of proinflammatory mRNAs67. Mitogen-activated protein kinase (MAPK)
signalling pathways, which activate a number of inflammatory genes, are downregu-
lated by GCs through induction of a MAPK downregulator, mitogen-activated pro-
tein kinase phosphatase-168,69. Activated GR reduces the transcriptional activity of
the pro-inflammatory transcription factor nuclear factor kappa-light-chain-enhancer
of activated B cells (NF-κB) through interaction with co-repressor molecules that
reduce RNA polymerase 2 chromatin remodelling as well as histone acteylation via
histone deacetylase-268,70.
Dexamethasone
Dex is a synthetic glucocorticoid developed in 1957 by MERCK71 and is used in both
medicine, for its anti-inflammatory and immunosuppressant effects, and research, as
a GR agonist. It has a long half-life and is 25 times more potent an agonist for the GR
than cortisol72, while having a minimal mineralocorticoid effect. In accordance with
it’s critical role in public health, Dex is on the WHO list of essential medicines73†.
Side effects
Considering the wide use of GC medication, the effects of GCs at therapeutic levels
constitutes a class of effects on their own. For example, drug induced high GC levels
∗http://www.world-sepsis-day.org/CONTENTPIC/2015_WSD_FactSheet_long_English.
pdf
†http://www.who.int/medicines/publications/essentialmedicines/EML2015_
8-May-15.pdf
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have been shown to cause osteoporosis74, delayed wound healing75, myopathy76–78,
increased risk of infection79, hyperglycemia and “steroid diabetes”80. Repeated ex-
posure to GCs over long periods of time has been shown to permanently damage
memory recollection leading to “steroid dementia”60,81,82.
Selective glucocorticoid receptor modulators (SEGRMs) are a class of drugs,
which exhibit the desirable properties of glucocorticoids but have reduced side effect
profiles83. SEGRMs achieve dissociation of positive and negative side effects of GCs
by selectively activating GR mechanisms of action, usually increasing transrepres-
sion and decreasing transactivation. For example, compound A84, a non-steroidal
SEGRM, has agonist activity for the GR but does not induce GR dimerisation,
therefore the activated GR remains a monomer and induces transrepression. Cush-
ing’s syndrome is a collection of symptoms brought about by sustained high levels
of GC exposure85, primarily in the form of medication but in some cases by GC
secreting tumors. The symptoms include: high blood pressure, abdominal obesity,
round red face, a fat lump between the shoulders, weak muscles, weak bones, acne
and fragile skin. Usually, this condition is treatable either by tapering off GC med-
ication or removal of GC secreting tumors; however, if the pituitary is damaged
medication is required to replace its lost function.
Resistance
GC resistance is caused by a variety of mechanisms such as familial resistance86, GR
modification and downregulation87,88, defective histone acetylation70,89, increased
GRβ expression90–92, GC eﬄux93,94, pro-inflammatory transcription factors95,96 and
upregulation of macrophage migration inhibitory factor97. Owing to the high de-
mand for anti-inflammatory treatments, a number of therapeutic options for re-
versing GC resistance are being investigated and developed such as the GC eﬄux
blockers, verapamil and quinidine, among others98. Small molecule inhibitors and
monoclonal antibodies are being developed to inhibit the action of macrophage mi-
gration inhibitory factor99 and there is interest in the ability of SEGRMs to restore
GR levels as either concomitant with or subsequent to GC therapies. The diverse
mechanisms of GC resistance are often simultaneously active, which frustrates at-
tempts to ameliorate them and, together with the side effects of GCs, present a
major obstacle to the development of long term GC based treatments.
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2.2 The glucocorticoid receptor
The GR mediates the effects of cortisol and other endogenous50,100,101 and syn-
thetic102–104 GCs. Ligand activated GR acts as a transcription factor104, binding to
positive or negative GREs, up or down regulating genes, or as a repressor, binding to
other transcription complexes, as shown in Figure 2.5. Like other steroid hormone
receptors, the primary function of the GR is to regulate protein-coding genes that
effect development, metabolism and immune responses, as discussed in Section 2.1.4.
GRs are present throughout the body105 albeit at varied concentrations depending
on tissue type106, inter individual variation107, physiological conditions108 and dis-
ease state109. Considering the anti-inflammatory affects of GCs, further study into
the GR is warranted.
2.2.1 Protein structure
The GR is a member of the nuclear receptor superfamily of steroid receptors. The
members of this family have common structural layout with a moderately conserved
activation domain, which includes the N-terminal domain (NTD), a highly conserved
DNA binding domain and the moderately conserved ligand-binding domain (LBD),
which encompasses the C-terminal of the GR protein, shown in Figure 2.6. The
NTD contains the activation function 1, which plays a critical role in the activa-
tion of transcription110–112 and interacts with multiple transcription factors including
the TATA and CREB binding proteins. Serine phosphorylation of S203, S211 and
S226 also influences GR function113–115. The DBD contains regions necessary for
dimerisation, DNA binding and transcription factor association. The LBD pos-
sesses a globular ligand binding pocket of 12 helices and includes regions necessary
for dimerisation, co-factor association, transcription factor association116 as well
as regions involved in transactivation. Following ligand-binding, a ligand specific
conformational change is induced in helix 12 of the GR, which affects binding of
transcriptional intermediary factor 2, a co-activator protein, resulting in differential
activity between GR ligands117.
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Figure 2.6: Schematic representation of the glucocorticoid recep-
tor gene intron and exon layout as well protein structure and func-
tional domains. The common structural layout of nuclear receptor
consists of a moderately conserved N-terminal domain, which in-
cludes the activation domain, a highly conserved DNA binding do-
main (DBD) and the moderately conserved ligand-binding domain
(LBD), which encompasses the C-terminal of the receptor protein.
AF-1, Activation function 1; AF-2, Activation function 2; AP-1,
Activator protein 1; HSP, Heat shock protein; NF-κB, nuclear fac-
tor kappa-light-chain-enhancer of activated B cells. Reproduced
from Andrew McMaster and David W. Ray118.
2.2.2 Glucocorticoid receptor distribution
The promoter region of the human GR is activated by a broad range of transcription
factors that ensure its constitutive expression under multifarious physiological con-
ditions. As mentioned previously, GR concentration varies between tissues, which
governs the different effects GCs have on different parts of the body. Within the cell,
the GR protein is localized to specific locations with consequent effects on GR-GC
signal transduction.
Inter-tissue distribution
The level of GR varies between individuals107, tissues106, under different physiolog-
ical conditions108and under different disease states109. For example, GR in bone
marrow ranges from 1106 to 27000 GR molecules/cell108. MCF-7, a breast cancer
cell line, contains 29995 GR/cell119, SiHa, a uterine cervical cancer cell line, con-
tains 81000 GR/cell and Hep3B, a hematoma cell line, contains 43000 GR/cell120.
Considering this, and that there are tissue specific variations of GC activity while
GC concentration is similar between tissues, the GR level is likely the causative
parameter leading to differential GC activity between tissues120.
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Intra-cellular distribution
In the unliganded state, the GR resides as a protein complex with heat shock pro-
tein (Hsp) 90, Hsp70, p23 and one of the tertratricopeptide repeat (TPR)-domain
proteins121. Nuclear localization is governed by NL1 from amino acid 479-506122–124
and NL2 from 526-777122,124. Upon ligand binding, the association with Hsp90121,125
changes and TPR FK506-binding protein 52126 and importin-α127 bind. This com-
plex is translocated into the nucleus along the cytoskeleton by dynein. Nuclear local-
isation occurs in equilibrium without ligand-binding, however it shifts dramatically
towards nuclear import upon ligand-binding124,128. Following ligand withdrawal, the
GR rapidly dissociates from the DNA129 and relocates to transcriptionally inactive
sites within the nucleus130. Nuclear retention is mediated by the nuclear retention
signal of amino acids 442-456131. Export is slow and does not consume ATP, there-
fore it is likely via passive diffusion. Immunofluorescent nuclear import and export
studies with GRwt and compound A show similar results to the dimerisation defi-
cient GR mutant, GRdim, and Dex132,133, indicating that dimerisation may play a
role in nuclear import and export.
2.2.3 Ligand binding
The macromolecular GR protein contains a binding pocket that is sterically and
electronically complimentary to both natural ligand (owing to evolutionary pres-
sure) and synthetic ligand (owing to the associated increase in activity). This com-
plementarity network stabilizes the ligand-receptor complex such that it is thermo-
dynamically favoured over the dissociated complex134,135.
In the conventional lock and key model for receptor ligand interaction136, the
receptor-ligand complex remains static after ligand binding and therefore associ-
ation and dissociation occurs as a single reversible reaction. Thus, drug activity
can be quantified by conventional equilibrium parameters such as IC50 and Kd.
However, high-affinity drug-target reactions, those which bind in the nM or lower
Kd range, usually include a conformational change in the receptor-ligand complex,
which increases complex stability134,135,137–140. This conformational change is usually
described by either the conformational selection model or the induced fit model.
Conformational selection model
The conformational selection model states that there is an equilibrium between
a number of protein conformations with varied ligand binding affinity141. Upon
addition of ligand, the ligand binds to the receptor at a rate proportional to the
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quantity and affinity of each state. Regardless of the equilibrium position between
various states, this will result in the majority of receptors binding to ligand, as ligand
binding removes the higher affinity forms from the unliganded receptor conversion
substrate pool.
Induced fit model
In the induced fit model, a conformational change, which increases ligand affinity
to the receptor, occurs after ligand has bound to the receptor142,143. The com-
plementarity network in the ligand binding pocket is not optimally conformed for
ligand binding. After ligand binding, the receptor undergoes an isomerisation reac-
tion where the conformation of the complementarity network in the ligand binding
pocket adjusts in such a way that the affinity for the ligand increases.
The conformational selection and induced fit models are not mutually exclusive
and indeed most mechanisms are a compromise or combination of the two, which
results in the optimal affinity for a particular system144,145. The stable, ligand-
bound state reached in both models should be characterized by a potential energy
trough, which prevents interconversion between forms. The majority of conforma-
tional changes which occur result in modulation of recognition elements formed in
the original receptor ligand interaction. Thermodynamically, both models are equiv-
alent as the reaction path does not affect Gibbs free energy change. The shift in
affinity associated with these conformational changes can be quite substantial with
reports of changes up to 6 orders of magnitude146.
Residence time
The idea that receptor ligand half-life (t1/2) is a key factor determining in vivo
effectiveness of ligands has been put forward by multiple researchers137,138,140,147.
The drug-receptor complex t1/2 is the time for half of the receptor ligand complex to
dissociate and is calculated as
ln (2)
koff
. The residence time is directly proportional to
the stability of the states of the receptor-ligand complex with higher ligand affinity
and thus the energy barriers between these states148. In the in vivo environment,
drug and target concentrations fluctuate over time, whereas many metrics by which
drug activity is measured, such as Kd (Section 2.3.1) and IC50, are determined under
equilibrium conditions. Often residence time will be inadvertently optimized during
the optimization of Kd
137–139; therefore, understanding the relationship between
structure and function is crucial to drug discovery.
Stellenbosch University  https://scholar.sun.ac.za
2.2. THE GLUCOCORTICOID RECEPTOR 18
2.2.4 Variants and mutants
The GR protein has a number of naturally occurring splice variants such as GRα,
GRβ and GRγ as well as artificial mutants generated for the purposes of research
such as GRdim and GRmon. The two primary splice variants, GRα and GRβ occur
as a result of alternative splicing of exon 9149,150, as shown in Figure 2.6. Generally,
papers referring to the GR are referring to GRα as it is the most widely expressed
and transcriptionally active isoform of the GR protein151,152. The GRβ splice variant
has substituted 50 C-terminal amino acids with 15 nonhomologous amino acids,
which, in concurrence with previous studies on steroid receptors, prevent binding
of agonists and subsequent activation153–155. The intact DNA binding domain is
still able to bind to GREs, therefore the GRβ acts as a dominant negative inhibitor
with respect to GRα156. Recent studies have shown that GRβ participates in the
regulation of a set of genes distinct from those regulated by GRα157.
GRdim
The majority of research into GR homodimerisation has focused on the DBD where
it has been shown that dimerisation is dependent on the 5 amino acids in the second
zinc finger of the DBD158. A dimerisation deficient mutant, GRdim, was established
in 1998 with a point mutation, by an alanine to threonine conversion at amino
acid 458, in the region responsible for dimerisation, supposedly abrogating the pro-
cess158. GRdim mutants have been constructed for human159, GRA458T, mouse160,
GRA465T, and rat161, GRA477T. GRdim has become the most widely characterized
GR dimerisation mutant and has been used extensively in studies to elucidate the
relevance of dimerisation in GC activity. The validity of the GRdim mutant, as a
model for dimerisation deficiency, has been recently questioned as it has been shown
to dimerise partially159,162.
GRmon
In response to the growing concerns about GRdim, described above, a fully dimeri-
sation deficient mouse GR mutant, GRmon, has been developed162. This mutant,
which contains two mutations, one in the LBD, I634A, and one in the DBD, A465T,
showed no dimerisation at 0.1 µM Dex and severely abrogated dimerisation at 1 µM
Dex162. This suggests that there are multiple regions within the GR protein that
promote dimerisation to varying degrees.
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2.2.5 Concentration-dependent effects
As mentioned previously, GC concentration is nearly equal throughout the human
body at any given time whether under natural or exogenously stimulated conditions,
while GR concentration is known to vary. A study by Robertson et al. showed that
GR concentrations of 67.0, 152.6 and 283.9 fmol GR/mg protein, representing a two-
and four-fold GR increase over physiological concentrations, showed a basal induc-
tion increase of three- and ten-fold, and an efficacy increase of four- and 12-fold1.
Furthermore, over the same GR range, a potency increase of 650- and 2600-fold
was shown while the fold induction was 9, 10 and 11 for the low, medium and high
GR concentrations respectively. Wild type GR showed increased transactivation
potency at higher receptor concentrations, which was not mirrored by increased
concentrations of GRdim shown in Figure 2.7, therefore, dimerisation is crucial for
dose-dependent increase of GR potency.
Until recently, the GR concentrations causing these effects had not been mea-
sured nor had the molecular mechanism been described. A recent study by Robert-
son et al.1 showed that ligand-independent dimerisation is responsible for positive co-
operative ligand binding as well as an increase in affinity and that ligand-independent
dimerisation increases the GC potency and causes a shift in bio-character. Their
observations showed an increase in potency far greater than could be accounted for
by cooperative binding alone, suggesting basal priming of the GR through ligand-
independent dimer loading onto DNA.
Chromatin Immunoprecipitation studies show that unliganded GR dimers bind
GRE while monomers do not1. This supports earlier electromobility shift assays
which showed that ligand independent dimers can bind to DNA with much greater
affinity than unliganded monomers, with Kds of 1.21 and 62 nM, respectively
163.
This is substantiated by fluorescent resonance energy transfer (FRET) results show-
ing unliganded dimers in the nucleus1. This indicates a hierarchy of binding affinity
to DNA: liganded dimerised GR > unliganded dimerised GR ≥ liganded monomeric
GR > unliganded monomeric GR.
Stellenbosch University  https://scholar.sun.ac.za
2.2. THE GLUCOCORTICOID RECEPTOR 20
Figure 2.7: Potency of dexamethasone-induced transactivation
increases with increased wild-type glucocorticoid receptor concen-
tration but not with the dimerisation deficient mutant. Robertson
et al. found that GC transactivation potency increased 2600-fold
with an increase in GR concentration and that this effect was elim-
inated when dimerisation was abrogated1.
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2.3 Modelling glucocorticoid receptor signal
transduction
Conceptually, steroids are signals, sent from one part of the body to another, which
are received by their cognate steroid receptors. A plethora of factors, such as hy-
drophobicity of the ligand164, shuttling of receptor across boundaries within the
cell128 and cellular co-factor milleu165, influence the transduction of this signal often
in seemingly paradoxical ways. Great strides have been made in delineating these
factors166, specifically with a systems approach, and as such there is an opportunity
for the development of functionally useful predictive models in this field. Molecular
biological systems are complex and contain numerous intricately cross-linked sys-
tems, which vary in their degree of influence on each other. Therefore computational
models have a large scope for expansion that improves their function. The formu-
lation of a model requires a working understanding of which systems to include or
exclude and how to compensate for any influences excluded systems may have.
2.3.1 Pharmacodynamic characteristics
Various measurements have been developed to describe drug reaction pharmaco-
dynamics, such as Kd and Hill coefficient. These form the basis of mathematical
modelling studies in this field.
Dissociation constant
The dissociation constant, Kd, is a type of equilibrium constant, which describes
the propensity for a complex to dissociate into two molecules. The physical inter-
pretation of Kd is that when the concentration of one of the substrates is equal to
Kd, half of the molecules of the other substrate will be complexed with the first
substrate. Given the reaction:
[R] + [L]
kon⇀↽
koff
[RL]
The affinity between the receptor, R, and ligand, L can be described by Kd:
Kd =
[R][L]
[RL]
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The smaller the Kd, the higher the affinity of R for L. Less commonly, the propensity
that a liganded or unliganded receptor has for dimerisation is also described by Kd:
[R] + [R]
kon⇀↽
koff
[RR]
Kd =
[R]2
[RR]
At equilibrium the rates of the forward and reverse reactions are equal, which leads
to a kinetic definition of Kd:
[R][L]kon = [RL]koff
[R][L]
[RL]
=
koff
kon
Kd =
koff
kon
The Kd rate equation presumes that there are no competing reactions present; how-
ever, it can be expanded to include these.
Hill equation and cooperative binding
The relationship between ligand concentration and occupancy of a receptor the
reaction of a ligand binding to a macromolecule is given by the Hill equation167
below:
σ =
[L]n
K nd + [L]
n
where σ represents the fractional occupancy of the receptor, [L] represents the free
ligand concentration, Kd represents the apparent dissociation constant (often using
the symbol K0.5) and n represents the Hill coefficient, the degree of cooperativity.
Cooperativity is a measure of the degree to which binding of a ligand influences the
binding of subsequent ligands. A Hill coefficient > 1 indicates that a ligand binding
enhances the binding of subsequent ligands while a Hill coefficient < 1 indicates the
inverse, that a ligand binding inhibits the binding of subsequent ligands. Naturally,
multiple binding sites are a prerequisite for cooperative binding to occur. In terms
of application, this equation can be fit to a saturation binding curve to determine
Kd and Hill coefficient.
[L] =
Bmax
10n×(logKd−log [L]) + 1
where Bmax represents the maximum amount of specific binding or the total receptor
concentration.
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2.3.2 Topological aspects of nuclear receptor signal trans-
duction
Accurate model generation requires a thorough understanding of the subject mech-
anism as well as of connected systems, which may need to be compensated for, if
not incorporated, in the model. Several mechanisms have been identified that mod-
ulate the response of a nuclear receptor system to changes in the concentration of
ligand166.
Non-DNA bound nuclear receptors
In the classical model of nuclear receptor activation the nuclear receptors are not
present in the cytoplasm168,169, but are bound to response elements on the DNA,
waiting to be activated by ligand. However, the nuclear receptors greatly outnumber
the response elements, so that the majority of nuclear receptors are not DNA bound.
For example, the number of GRs is approximately 100-fold higher than the number
of active response elements calculated from the number of GRE170,171 and GR172,173
per cell (although the GR has been shown to bind to other DNA elements174). A
higher concentration of nuclear receptor leads to a higher concentration of liganded
nuclear receptor when ligand is added and, consequently, results in more liganded
nuclear receptor bound to the response element, thereby vastly improving responses
over DNA bound nuclear receptor alone. Additionally, DNA-bound nuclear receptor
is targeted for ubiquitination and degradation175, which constitutes a futile cycle
when the nuclear receptor is unliganded.
Nuclear receptor in the cytoplasm
The nuclear receptors derive their name from initial studies that observed them
located mostly in the nucleus, despite them mediating extracellular signals168. Sim-
ulations with nuclear receptor exclusively in the nucleus show a slow response to ad-
dition of ligand; however, the magnitude of the steady-state response is increased166
relative to simulations with nuclear receptor in cytoplasm. The rate at which un-
chaperoned ligand diffuses across the cytoplasm is not sufficient to match the rate
of ligand sequestration by nuclear receptor in the nucleus166. This is in part owing
to the hydrophobic nature of steroids, which causes them to remain bound to the
plasma membrane rather than enter the cytoplasm with partition coefficients164 of
over 1000. Furthermore, the width of the plasma membrane is significantly smaller
than the radius of the cytoplasm. For example, the diffusion rate for cortisol is esti-
mated at approximately 6×10−12 m2.s-1 and the diffusion rate for nuclear receptor is
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one sixth of this amount, as determined from protein diffusion constants166. It may
therefore appear paradoxical that cytoplasmic nuclear receptor would shuttle ligand
across the cytoplasm. However the concentration of nuclear receptor vastly exceeds
that of free ligand and therefore cytoplasmic nuclear receptor shuttles ligand to the
nucleus at rates of up to 25 times higher than if the nuclear receptor were present
in the nucleus alone.
Nuclear shuttling
In nuclear receptor signal transduction models that do not include nuclear shuttling,
ligand would have to be released at and diffuse across the nuclear membrane be-
fore binding to nuclear nuclear receptor to cause a transcriptional response. This
slows down the transcriptional response166; however, this problem is circumvented
by translocation of ligand-bound cytosolic nuclear receptor into the nucleus. Follow-
ing addition of ligand, cytosolic and nuclear nuclear receptor reach an equilibrium
with a lower nuclear nuclear receptor concentration than if nuclear receptor were
present in the nucleus alone, resulting in a lower transcriptional response166. Ad-
justing the ratio between nuclear and cytosolic nuclear receptor will shift the system
either towards a faster response or a more sensitive one and provides a mechanism
by which responsiveness in nuclear receptor systems can be modulated to the cell’s
requirements.
Another aspect that modulates nuclear receptor system responsiveness is the ab-
solute rate of shuttling, as increasing the rate at which liganded nuclear receptors
are moved into the nucleus will always improve the speed of the transcriptional re-
sponse166. However, the increased shuttling rate results in reduced specificity. Com-
pletely non-discriminatory shuttling at any rate would result in equal concentrations
of liganded nuclear receptor on either side of the nuclear membrane. This lowers
system responsiveness relative to specific shuttling as cytoplasmic liganded nuclear
receptor is increased, inhibiting ligand binding to nuclear receptor, and nuclear lig-
anded nuclear receptor concentration is decreased, weakening the transcriptional
outcome. Therefore a compromise needs to be reached between the absolute rate of
shuttling and the import/export ratio166.
The specificity of the nuclear receptor import system is achieved by binding of
importins selective to liganded nuclear receptor, which flag these nuclear receptors
for nuclear import166. These importins have to dissociate from the nuclear receptor
once inside the nucleus and travel back to the cytoplasm to regenerate the cyto-
plasmic importin pool. This results in an increase in the concentration of nuclear
importin, which, at high enough concentrations, will inhibit transcriptional response
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by sequestration of liganded GR166. Therefore, an importin gradient that drives
nuclear import of importin-bound liganded nuclear receptor and active importin
export, likely coupled to GTP hydrolysis, is optimal.
2.3.3 The glucocorticoid receptor dimerisation cycle
GR and ligand conversion reactions include an array of different species, as shown in
Figure 2.8, the concentrations of many of which are not feasible to be determined
experimentally. These reactions include the formation of heterodimers with other
steroid hormone receptors, oligomer states above dimers as well as incompletely
liganded dimers and higher oligomers. A partially liganded state can be achieved
either when a single ligand binds to the dimerised unliganded GR complex, as two
ligands cannot bind to an unliganded GR simultaneously, or when a liganded GR
binds to an unliganded GR. These states could be incorporated into the a model
using the Adair equation, however these additional states exist for short times and
have little influence on activity. Therefore, the exclusion of these reactions and
species should not significantly detract from the accuracy of a model of GR-ligand
binding.
A GR-3H-Dex radiolabelled ligand-binding study found a shift in Hill coefficient
from 1 to 1.72 over a GR concentration range of 67.0 ± 8.8 to 283.9 ± 23.8 fmol/mg
protein, which indicates an increase in cooperativity1. Ligand-independent dimeri-
sation and partially liganded states are a prerequisite for cooperative binding as each
GR monomer contains a single ligand binding pocket116. The same study showed
that cooperative ligand binding and increased ligand binding affinity were abolished
when dimerisation was abrogated with the GRdim mutant. Binding of a single lig-
and to a unliganded GR dimer increases the affinity of the dimer for a second ligand
by altering the energetics of binding176.
Thermodynamics
One of the principles of Gibbs energy is that the total standard Gibbs177 free energy,
and therefore Keq, for the conversion from the substrates to the products is the same
regardless of which pathway is taken. The result is that the Kd of a reaction could
be determined arithmetically by setting the product of all the Kds of a pathway
equal to those of another pathway or the Keq of the entire pathway. In the case of
the GR i.e.,
K2d1.Kd2 = Kd3.Kd4 = Keq
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Figure 2.8: The glucocorticoid receptor (GR) dimerisation cy-
cle. (A) Reaction 1, ligand binding to monomeric GR produces
monomeric liganded GR. (B) Reaction 2, monomeric liganded GR
associates to form dimeric liganded GR. (C) Reaction 3, unliganded
GR associates to form dimeric unliganded GR. (D) Reaction 4, lig-
and binding to dimeric GR producing dimeric liganded GR.
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the dimerisation of ligand bound GR is difficult to determine experimentally, how-
ever the ligand binding to monomeric and dimeric GR as well as the ligand inde-
pendent association can be determined. Figure 2.8 shows the two pathways for the
conversion of unliganded monomeric GR to liganded dimeric GR.
In the next chapter, the formulation of the model for the GR dimerisation cycle will
be described, as well as an analysis of the GR ligand binding system.
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Chapter 3
Modelling the glucocorticoid
receptor dimerisation cycle
The central focus of this project was to develop a mathematical model of the reac-
tions of the GR dimerisation cycle that included: ligand binding to GR monomer,
dimerisation of liganded GR, ligand-independent dimerisation of GR and binding
of ligand to unliganded GR dimers (Figure 2.8). The variables of this model were
populated using experimental values obtained from literature1. Additionally, GR-
3H-Dex whole cell time course binding experiments were conducted at 20 nM and
40 nM 3H-Dex in order to the determine kinetic parameters necessary to perform
time dynamic simulations with the model. A compartmental model was formulated
that included three compartments, representing cells with different concentrations
of GR. Finally, these models were to used to simulate saturation binding data at
different GR concentrations and distributions, providing insights into the influence
of dimerisation on GR signal transduction.
3.1 Formulation of the mathematical model
Reaction kinetic models require both rate and stoichiometric equations to perform
computational simulations. The reaction scheme in Figure 2.8 was used as the
basis for formulating a model capable of simulating the GR dimerisation cycle. The
following equations were used in the model, they are numbered for easier differenti-
ation between reaction rates as well as reaction rate constants:
Reaction 1, ligand binding to unliganded GR monomer (Figure 2.8 (A)):
R + L
kf1⇀↽
kr1
RL
28
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v1 = kf1[R][L]− kr1[RL]
Reaction 2, dimerisation of liganded GR monomer (Figure 2.8 (B)):
2RL
kf2⇀↽
kr2
(RL)2
v2 = kf2[RL]
2 − kr2[(RL)2]
Reaction 3, dimerisation of unliganded GR monomer (Figure 2.8 (C)):
2R
kf3⇀↽
kr3
R2
v3 = kf3[R]
2 − kr3[R2]
Reaction 4, binding of two ligands to unliganded GR dimer (Figure 2.8 (D)):
R2 + 2L
kf4⇀↽
kr4
(RL)2
v4 = kf4[R2][L]
2 − kr4[(RL)2]
where R represents receptor, L represents ligand, v represents reaction rate and kf
and kr represent forward and reverse reaction rate constants, respectively. These
reactions were compiled in “.psc” files for use in Python based simulations using the
PySCeS environment178, see Appendices A to C for more details. All species and
ligand concentrations as well as rate constants were in nM.
Internal consistency
Following formulation, the model was tested for internal inconsistencies. Figure 3.1
shows that all reaction rates reached zero and the concentrations of all GR species
reached equilibrium when the model was initiated with 20 nM ligand. This simula-
tion was performed with koff values of 52.3, 6.4, 83.0 and 211.5 min
-1 for reactions
1 to 4 respectively, a kon value of 1 nM
-1.min-1 for reactions 1 to 3 and 1 nM-2.min-1
for reaction 4 and a GR concentration of 54 nM. The koff values used in this sim-
ulation were determined in Section 3.2. The system simulated in this project was
thermodynamically closed, with no external addition or removal of GR species. In a
closed system, the results of this simulation demonstrates that the stoichiometry of
the model does not violate the law of conservation of matter and that the reaction
scheme is logically consistent.
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A
B
Figure 3.1: The GR dimerisation cycle mathematical model is
internally consistent. The model was initiated with koff values of
52.3, 6.4, 83.0 and 211.5 min-1 for reactions 1 to 4 respectively, a
kon value of 1 nM
-1.min-1 for reactions 1 to 3 and 1 nM-2.min-1 for
reaction 4, a GR concentration of 54 nM and a ligand concentration
of 20 nM and simulated until the concentrations of all GR species
and free ligand reached equilibrium and all reaction rates reached
zero. (A) The rates for all reactions reached zero. (B) All GR
species concentrations reached equilibrium. R1, reaction 1, ligand
binding to unliganded GR monomer; R2, reaction 2, dimerisation of
liganded GR monomer; R3, reaction 3, dimerisation of unliganded
GR monomer; R4, reaction 4, binding of two ligands to unliganded
GR dimer.
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Excluded reactions
The model formulated in this project aimed only to include the reactions of Fig-
ure 2.8 as it was hypothesized that this would allow simulation of the influence of
GR concentration on Kd and Hill coefficient, as discussed in Section 2.3.3. Proxi-
mate reactions, such as those shown below, were examined for potential ancillary
influences on the hypothesis and simulations.
Reaction 4 (two ligands binding to dimerised GR) assumes 100% cooperativity,
which is physically impossible as one ligand cannot force another to bind immedi-
ately. This could be resolved by splitting this reaction into two sequential binding
reactions as shown below:
R2 + L⇀↽R2L
R2L+ L⇀↽(RL)2
The first reaction pair describes a single ligand binding to an unliganded GR dimer.
The second reaction pair describes a ligand binding to a GR dimer with a single
ligand already bound. The latter reaction would likely have a lower Kd, indicating
a higher ligand affinity, owing to an increase in cooperativity brought about by the
binding of the first ligand. Obtaining the binding constants for these reactions was
not possible at this time as they could not be isolated from the rest of the GR
dimerisation cycle. Considering that there is no evidence that a GR dimer bound
to a single ligand is biologically active and that the thermodynamic influence of
a linear reaction path is maintained when combining multiple reactions, including
these reactions individually was deemed unnecessary.
Currently, there is no evidence to support or reject the potential reaction of a
liganded GR monomer binding to a unliganded GR monomer, shown below:
RL+R⇀↽R2L
The product of this reaction would be a single ligand bound to GR dimer, which
would feed into the second reaction above. This reaction was excluded on the basis
that the products formed would be rapidly converted to the end product, minimizing
any impact they have on the system.
A recent study has shown that the GR forms oligomerisation states higher
than dimer179. It is unclear whether this applies to both liganded and unliganded
oligomers. Oligomers could be formed by sequential addition of ligand, shown in
Stellenbosch University  https://scholar.sun.ac.za
3.1. FORMULATION OF THE MATHEMATICAL MODEL 32
the equation below, or by concatenation of GR oligomers of any order.
Rn +R⇀↽Rn+1
These reactions were excluded on the basis that there is limited evidence for their
existence and influence on GR function.
Various additional time-dependent influences on the ligand-GR system may be-
come relevant depending on the situation being simulated. For example, steroids
are removed from the cells by glucuronidation180, which lowers ligand concentration
over time, causing all GR species to revert to their unliganded forms. In this model
it was assumed that free ligand concentration remains stable as the simulations
were run over relatively short periods of time. Under this condition, ligand would
be continually replenished by an endogenous or exogenous source. Additionally, se-
questration of liganded GR to DNA removes this species from the product pool of
the GR dimerisation cycle thereby increasing the flux through this pathway until
the GREs became saturated. Presumably, the binding of GR dimers to DNA is a
major reaction determining the transcriptional outcome of the ligand-GR system
and would be incorporated into a model that aimed to simulate this.
Ligand depletion
The initial formulation of the model did not have ligand concentration fixed. With-
out ligand fixed, the simulated saturation binding data slope shifted to the right for
medium and high GR concentrations (Figure 3.2), despite the expected increase in
cooperativity, which should have resulted in a shift to the left. This observation can
be attributed to ligand sequestration, where ligand bound to GR is removed from
the reactant pool lowering the effective free ligand concentration, thereby giving a
result that falsely appears as if potency had lowered. In in vivo binding assays, to-
tal ligand greatly exceeds total receptor. Consequently, ligand depletion in binding
experiments is negligible, usually < 5%, and was justifiably fixed in the model.
Shifts in Kd and Hill coefficient
One of the objectives of this project was to identify the aspects of the GR dimerisa-
tion cycle mechanism that causes Kd to decrease and the Hill coefficient to increase
as GR concentration is increased, as discovered by Robertson et al.1. To this end, the
model was reduced into two simpler versions, the classical GR activation pathway,
containing Reaction 1 (Figure 2.8), ligand binding to unliganded GR monomer
and Reaction 2, dimerisation of liganded GR monomer, as well as the alternate GR
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Figure 3.2: Model simulation showing ligand depletion. The
model was initiated with koff values of 52.3, 6.4, 83.0 and 211.5 min
-1
for reactions 1 to 4 respectively and a kon value of 1 nM
-1.min-1 for
reactions 1 to 3 and 1 nM-2.min-1 for reaction 4, GR concentrations
of 54, 123 and 229 nM and saturation binding data was simulated
with and without ligand fixed.
activation pathway containing Reaction 3, dimerisation of unliganded GR monomer
and Reaction 4, binding of two ligands to unliganded GR dimer. Saturation binding
data was simulated and Hill equations fitted, using the method described in Sec-
tion 5.2.1, at GR concentrations from 50 to 250 nM and with values of 52.3, 6.4, 83.0,
211.5 nM for kr1, kr2, kr3 and kr4 respectively (Figure 3.3); refer to Section 3.2 for
determination of these values. The complete model showed that Kd decreased from
27.1 to 21.7 nM as GR concentration increased and the Hill coefficient increased
from 1.36 to 1.60 (Figure 3.3 (A)). The classical pathway only model showed
that Kd reduced from 20.7 to 10.8 nM as GR concentration increased, Hill coeffi-
cient increased from 1.23 to 1.30 (Figure 3.3 (B)). The alternate pathway only
model, showed the Kd reduced from 35.9 to 24.6 nM as GR concentration increased,
while Hill coefficient increased from 1.56 to 1.72 (Figure 3.3 (C)). These results
show that the complete, classical and alternate pathways contain the mechanism
by which Kd and Hill coefficient shift in response to a change in GR concentration.
The greater shift in Hill coefficient generated by the alternate only pathway when
compared to the classical only pathway may indicate that this pathway contributes
more to this phenomenon.
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Figure 3.3: The Kd and Hill coefficient of the classical, alternative
and combined pathways change in response to a change in GR con-
centration. Simulated saturation binding data was generated over
a range of GR concentrations using the model containing (A) both
pathways, (B) only the classical pathway; ligand binding to GR
monomer and dimerisation of liganded GR dimers and (C) only
the alternate pathway; ligand-independent dimerisation and ligand
binding to GR dimer.
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3.2 Populating model variables at equilibrium
The reactions of the GR dimerisation cycle are reversible, therefore both forward
and reverse reaction rate constants need to be populated before the model can
be simulated. Populating the reaction rate constants is easier at equilibrium as
dissociation constants can be used instead of reaction rate constants, which are
more difficult to obtain. This is owing to the fact that the position of equilibrium
is not determined by the absolute values of the forward and reverse reaction rate
constants but instead by their ratio, as discussed in Section 2.3.1. Therefore, in
terms of populating model variables, the reverse reaction rate constant can be taken
as the dissociation constant and the forward reaction rate constant can be taken as
1.
3.2.1 Ligand binding to glucocorticoid receptor monomer
(kr1)
The dissociation constant for reaction 1, Figure 2.8 (A), ligand binding to GR
monomer, was determined in a system where dimerisation was eliminated, thereby
isolating this reaction from the rest of the GR dimerisation cycle. GRdim represents
this system and a Kd of 52.3 nM was obtained from GRdim
3H-Dex saturation
binding experiments found in literature1, which was used to populate kr1 in the
model. The literature showed that the Kd did not significantly change in response to
an increase in GRdim concentration1; however, considering that GRdim is known to
dimerise to some extent159,162, the Kd used in the model was taken from experiments
at the lowest GRdim concentration available.
3.2.2 Ligand independent dimerisation (kr3)
Similarly to reaction 1, the dissociation constant for reaction 3, Figure 2.8 (C),
unliganded GR dimerisation, was determined in a system where this reaction was
isolated from the rest of the GR dimerisation cycle, by measuring dimerisation before
ligand addition. Data, generated in Monkey Kidney Fibroblast-like Cells (COS-1)
cells transiently transfected with both Cyan fluorescent protein (CFP)- and Yellow
fluorescent protein (YFP)-tagged GRwt and measured for FRET before and after
Dex stimulation, was taken from literature1 and shown in Table 3.1.
The percentage of the GR molecules present as monomers and dimers was cal-
culated (Table 3.2) from the concentration of monomers and heterodimers in Ta-
ble 3.1. Kd was calculated from these and an average value of 83 nM was obtained.
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Table 3.1: Ligand-independent dimerisation of three concentra-
tions of GR before addition of Dex. COS-1 cells were transiently
transfected with both CFP- and YFP-tagged GRwt and measured
for FRET before and after Dex stimulation. Saturation binding,
used to determine GR concentration, and FRET data were ob-
tained from literature1. Equal transfection and expression of CFP-
and YFP-tagged GR was assumed. Therefore, CFP-GR and YFP-
GR total was calculated as 1/2 total GR. Maximum CFP-GR-YFP-
GR heterodimer (CY) was calculated as 1/6th of the total GR. CY
was calculated as the ratio of FRET before and after Dex stimula-
tion multiplied by the maximum CY concentration. CFP-GR and
YFP-GR monomer concentrations were calculated as described by
Robertson et al.1.
Total [GR]
(nM)
Total [CFP- or
YFP-GR] (nM)
Maximum
[CY] (nM)
[CY]
t=0 (nM)
[CFP- or YFP-
GR] t=0 (nM)
Low 54 27 9.0 3.71 15.9
Medium 123 61.5 20.5 11.83 25.9
High 229 114.5 38.2 24.94 39.4
Table 3.2: Calculation of the Kd of ligand-independent dimeri-
sation. % GR monomers was calculated by taking the ratio of
CFP-GR or YFP-GR without Dex stimulation (Table 3.1) to the
total CFP- or YFP-GR. % GR dimers was calculated from % GR
monomers. GR concentration was determined by saturation bind-
ing. Kd was calculated by converting the % GR monomers and %
GR dimers to concentrations and using the mass action form of the
Kd formula.
% GR
monomers
% GR
dimers
[GR] monomer
(nM)
[GR] dimer
(nM)
K d (nM)
Low 59 41 31.8 11.1 91
Medium 42 58 51.8 35.5 75
High 34 66 78.8 74.8 83
Average K d 83
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3.2.3 Liganded receptor dimerisation and ligand binding to
glucocorticoid receptor dimer (kr2 and kr4)
Obtaining the Kd for reactions 1 and 3 was made possible by the availability of a
convenient means of isolating these reactions from the rest of the GR dimerisation
cycle. However, this is not the case for reactions 2 and 4. Consequently, these dis-
sociation constants were determined by fitting model-simulated saturation-binding
data to experimental saturation binding data generated using COS-1 cells tran-
siently transfected with either 40, 400 or 4000 ng GRwt-encoding plasmid DNA.
There is a thermodynamic relationship between Kd4 and Kd2, shown below, which
relates these values by a constant,
Kd3
Kd1
, determined previously and therefore only a
single variable needs be fitted to determine both.
K2d1 ·Kd2 = Kd3 ·Kd4
Kd2 =
Kd3
K2d1
·Kd4
Fitting of kr2 and kr4 by simultaneous regression
One of the goals of formulating the model was to use it to simulate specific binding
over a range of GR concentrations, therefore binding constants were determined by
fitting to data sets generated with a low, medium or high GR concentration. This
was achieved by simultaneous regression of simulated saturation binding data to
low, medium and high GR experimental saturation binding data sets obtained from
literature1 using the method described in Section 5.2.3. A kr4 of 211.5 min
−1 and a
kr2 of 6.4 min
−1 was fitted and incorporated into the model.
Weighting of data points
The data sets used for fitting kr2 and kr4 were derived from multiple saturation
binding experiments and the confidence in each individual data point varied. Three
methods of fitting were attempted in an effort to reduce the chance of the results
being detrimentally affected by error in the data. First, the distance between model-
simulated saturation binding data and the average of each experimental data set
was minimized without weighting. Second, the distance between model-simulated
saturation binding data and the average of each experimental data set was min-
imized with weighting. Third, the distance between model-simulated saturation
binding data and each experimental data point individually was minimized. Fitting
to unweighted averages can skew the data therefore this method was discounted.
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Regression on all data points individually resulted in fitted values for kr4 and kr2
that more closely simulated experimental data (Figure 3.4) than regression to the
weighted averages of each data point, therefore these values were used further.
Figure 3.4: Experimental GRwt saturation binding data plotted
against model-simulated saturation binding data. COS-1 cells were
transiently transfected with either low, medium or high amounts
of GRwt and incubated with a range of 3H-Dex for 4 h. The kr4
and kr2 values of the GR dimerisation cycle model were fitted by
simultaneous regression between the low (53 nM), medium (108
nM) and high (192 nM) GR experimental data and simulated sat-
uration binding data generated with the same GR concentrations.
Displayed above are the low, medium and high GR experimental
data sets (blue, green and red dots respectively) and simulated sat-
uration binding data generated at low, medium and high GR (blue,
green and red lines respectively) with the best-fit values of kr4 and
kr2, 211.5 and 6.4 min
-1 respectively. Experimental data reproduced
from Robertson et al.1.
3.2.4 Model comparison to experimental data
The accuracy of the model was assessed by comparing simulated saturation binding
data to Hill equations fitted to experimentally generated saturation binding data.
Hill equations were fitted to GRwt saturation binding data, obtained from Steven
Robertson and shown in Figure 3.5, which produced Kds of 42.2, 19.8 and 13.2 nM
and Hill coefficients of 1.11, 1.56 and 1.64 for low, medium and high GR, respectively.
These results differed slightly from their study of origin, which reported Kds of 49.1,
23.9 and 16.8 nM and Hill coefficients of 1.08, 1.57 and 1.72 for low, medium and high
GR, respectively. This discrepancy was due to fitting a single site hyperbola to the
data to obtain theKd and Bmax before fitting Hill equations to obtain Hill coefficients
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with these values as parameters, whereas in this study Kd, Hill coefficient and Bmax
were obtained from a single fit of a Hill equation. The results showed that the GR
binding to Dex increases in potency, i.e. has a lower Kd, when GR concentration is
increased, which is consistent with previous findings.
Figure 3.5: Experimental GRwt saturation binding data fitted
with a Hill equation. COS-1 cells were transiently transfected with
GRwt and incubated with a range of 3H-Dex for 4 h. Experimental
data were obtained from Robertson et al.1. Hill equations were
fitted to each data set individually and plotted.
Model simulated saturation binding data was generated at low, medium and
high GR, fitted with Hill equations and plotted against experimental data, shown in
Figure 3.4. The Kds for model-simulated saturation binding data were 22.3, 19.6
and 18.2 nM, while the Hill coefficients were 1.45, 1.57 and 1.65 for low, medium
and high GR, respectively. The r2 values for the model-simulated saturation binding
data fitted to the experimental data were 0.860, 0.969 and 0.890 for low, medium
and high GR, respectively. Therefore, model simulations were most accurate at
medium GR concentrations and less so at low and high GR concentrations. To sum
up, the model was able to replicate a shift in Kd and Hill coefficient with a change
in GR concentration, while keeping the kinetic rate constants of each component
reaction the same in all cases. However, the observed parameter changes were not
as dramatic as those seen in the experimental data.
3.2.5 System analysis using the GR dimerisation model
with populated variables
Once the model parameters had been populated, the model was used to further
analyse the behavior of the GR dimerisation system. Simulated saturation binding
Stellenbosch University  https://scholar.sun.ac.za
3.2. POPULATING MODEL VARIABLES AT EQUILIBRIUM 40
data was generated, as described above, over a range of GR concentrations and Hill
equations were fitted at each concentration, displayed in Figure 3.6 against exper-
imental saturation binding data. The model-simulated saturation binding data at
5 nM and 10000 nM GR represent the theoretical limits of the model system and the
results were comparable to the saturation binding data of COS-1 cells transfected
with 40 and 4000 ng DNA, respectively. Model simulations at a GR range between
38 to 230 nM represent physiologically relevant levels of GR and were comparable
to saturation binding data of COS-1 cells transfected with 400 ng plasmid DNA.
The slope shifted to the left with an increase in GR concentration indicating that
the Kd decreased and therefore ligand binding to GR became more potent. The
GR concentration-dependent shift in specific binding was greater at higher ligand
concentrations than at lower concentrations, resulting in a steeper slope. This indi-
cates that the Hill coefficient increased as GR concentration increased and that the
increase in specific binding in response to ligand was greater at higher GR concen-
trations.
Figure 3.6: Hill equations fitted to model-simulated saturation
binding data generated over range of GR concentrations. The GR
dimerisation cycle model was used to simulate saturation binding
experiments at GR concentrations of 5 nM (blue line), 100000 nM
(the red line) and a range from 38 to 230 nM (green lines). COS-1
cells were transiently transfected with either low, medium or high
(blue, green and red dots respectively) amounts of GRwt and in-
cubated with a range of 3H-Dex for 4 h. Experimental data repro-
duced from Robertson et al.1.
Hill equations were fitted to the simulated saturation binding experiments per-
formed in Figure 3.6 to obtain Hill coefficients, shown in Figure 3.7 (A), and
the dissociation constants, shown in Figure 3.7 (B), over a range of GR con-
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centrations. The Hill coefficient increased from 1.35 at 34 nM to 1.65 at 249 nM
and Kd decreased from 25 to 18 nM over the same range. Both these trends were
non-linear, indicating that the GR concentration-dependent shifts in Kd and Hill
coefficient are greater at lower GR concentrations than at higher concentrations.
This simulated GR dependent shift in Kd and Hill coefficient was consistent in di-
rection with findings in literature, however it did not mimic the magnitude of the
shift found experimentally1.
A B
Figure 3.7: Model generated (A) Hill coefficients and (B) Kd val-
ues plotted against GR concentration. Simulated saturation bind-
ing data was generated over a range of GR concentrations and a
Hill equations were fitted at each concentration.
The model was run to equilibrium without ligand with GR concentrations from
38 to 230 nM and the percentage of the GR population as unliganded GR dimers
was calculated. This effectively reduced the model to only the ligand-independent
dimerisation reaction and showed that the percentage of the GR population as un-
liganded “pre-formed” dimers increased as GR concentration increased. The same
trends were observed when Kd (Figure 3.8 (B)) and Hill coefficients (Figure 3.8
(A)) were plotted against GR dimers. Ligand-independent dimerisation is likely the
mechanism by which cooperativity increases as GR monomers only contain a single
ligand binding site and therefore cooperativity is impossible, while GR dimers con-
tain two ligand binding sites. The formation of ligand-independent dimers correlated
linearly with an increase in Hill coefficient (Figure 3.8 (A)) and with a decrease
in Kd (Figure 3.8 (B)). This was consistent with the hypothesis presented by
Robertson et al.1 that an increase in GR leads to an increase in ligand-independent
dimers, which causes an increase in cooperativity and ligand affinity. However, con-
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sidering that Figure 3.3 (B) showed that this shift will occur even in the absence
of ligand-independent dimers, it is likely that there are additional mechanisms that
cause this effect.
A B
Figure 3.8: Model generated Hill coefficients (A) and Kd values
(B) versus percentage total GR as dimers. The model was simu-
lated to equilibrium without ligand over a range of GR concentra-
tions and the % of the GR population as GR dimers was calculated.
Saturation binding data was simulated using the model over a range
of GR concentrations and a Hill equation was fitted from which Hill
coefficients and Kd were obtained at each concentrations.
3.3 Whole cell binding time course
In order to make the model time dynamic the kinetic parameters of the model would
have to be determined. To this end, whole cell binding experiments at 20 nM and
40 nM 3H-Dex with COS-1 cells transiently transfected with with 40, 400 or 4000 ng
of either GRwt or GRdim plasmid were conducted and used to determine the kon
and koff values of
3H-Dex-GR binding. Representative graphs of each experimental
condition consisting of at least two individual experiments performed in triplicate
normalized to 40 nM binding at 4 h and pooled are shown in Figure 3.9. With the
40 nM 3H-Dex incubation, binding of 3H-Dex to GR reached a plateau at approxi-
mately 90 min for GRwt and 120 min for GRdim. However, with the 20 nM 3H-Dex
incubation the specific binding appeared not to reach a plateau within the 4 h range
of the experiment. This is shown on the graph as a lack of convergence between the
20 and 40 nM model fits despite Bmax being shared between both lines. The model
fits to the 20 nM specific bindings appear to converge to the model fits to the 40 nM
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specific bindings earlier for GRwt than for GRdim indicating that dimerisation may
increase the rate with which Dex binds to GR at lower 3H-Dex concentrations.
Transfection with 40, 400 and 4000 ng GRwt-encoding plasmid and subsequent
whole cell binding yielded Kds of 8.3, 2.23 and 0.91 nM, respectively. Although these
were not statistically significantly different, a trend of decreasing Kd with increasing
GR was shown (Figure 3.10 (A)). This trend was not observed for GRdim, which
yielded Kds of 8.23 18.55 and 7.97 nM for the same transfection conditions. The
koff values obtained from GRwt transfected cells decreased from 0.00739 to 0.00121
and 0.00070 min-1 for 40, 400 and 4000 ng plasmid DNA, respectively (Figure 3.10
(B)). Again, this trend was not observed for GRdim transfected cells where values
of 0.00454, 0.00591 and 0.00635 min-1 were obtained for the same quantities of plas-
mid DNA, respectively. No trend can be observed for kon where values of 8.91×105,
5.44× 105 and 7.64× 105 M-1.min-1 were found for GRwt, and 5.51× 105, 3.19× 105
and 7.97×105 M-1.min-1 were found for GRdim, for 40, 400 and 4000 ng, respectively
(Figure 3.10 (C)). Therefore, the basis for the GRwt concentration-dependent de-
crease in Kd can be found in the decrease in koff rather than an increase in kon.
Additionally, the koff values of medium and high GRwt transfections were approx-
imately 5 and 10 times less than those of their respective GRdim conditions. This
is in contrast to kon where there was no discernible pattern with respect to dimeri-
sation or GR concentration. This implicates dimerisation as a potential mechanism
that increases the ability of GR to hold on to ligand in a concentration-dependent
manner.
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GRwt GRdim
40 ng
400 ng
4000 ng
Figure 3.9: Whole cell time course binding experiments with low,
medium and high GRwt and GRdim. COS-1 cells were transiently
transfected with 40, 400 or 4000 ng of GRwt or GRdim plasmid
DNA and incubated with either 20 or 40 nM 3H-Dex for up to
4 h. Binding was determined by scintillation counting, scaled to
the 40 nM 4 h time point and the data was pooled for each ex-
perimental condition. Lines represent fits of the kinetic parameter
model described in Section 5.1.3 to both data sets. Results repre-
sent at least two independent experiments performed in triplicate.
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Figure 3.10: Kd, koff and kon values for low, medium and high
GRwt and GRdim. koff and kon were fitted to the data shown in
Figure 3.9 using the kinetic parameter model described in Sec-
tion 5.1.3 to both data sets with Bmax, Kd, kon and koff shared.
Unpaired t-tests were performed within each GR mutant and no
statistically significant differences were found. Results represent at
least two independent experiments performed in triplicate.
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3.4 Transfection efficiency and distribution time
course
Previous work on GR dimerisation has been based on the assumption that transfect-
ing with a greater quantity of GR-coding plasmid would result in a higher average
GR concentration per transfected cell. In order to evaluate this assumption, as well
as to optimize the Fluorescence-Activated Cell Sorting (FACS)-whole cell binding
experimental design, the level of GR expression in COS-1 cells transiently trans-
fected with eGFP-GR was tested over 120 h using FACS (Figure 3.11).
Expression of GR increased significantly from 24 to 48 h for 40, 400 and 4000 ng
transfected DNA (Figure 3.11 (A)). No significant differences were found between
expression at 48, 72 and 96 h although there appears to be a slight decrease in
expression at 96 h for all transfection conditions. There was a significant decrease
in GR expression at 120 h for all transfection conditions. Additionally, increasing
the quantity of transfected DNA from 40 to 400 ng caused a near two-fold increase
in the proportion of the population expressing GR after 48 h. Similarly, an increase
in transfected DNA to 4000 ng resulted in a near 3-fold increase over 40 ng DNA at
48 h with similar differences being observed at the other times tested. There is only a
single nucleotide difference between GRwt and GRdim genes160 and both expression
plasmids in this study were based on the pEGFP-C2 plasmid and therefore their
expression is expected to be comparable.
Cells were further categorized as expressing low, medium or high levels of GR.
This distribution is relative to the total number of transfected cells (Figure 3.11
(B)). No significant differences were found in the relative proportion of the popu-
lation expressing low, medium or high GR between the 40, 400 and 4000 ng DNA
transfected populations at 48 or 72 h. This contradicts the analysis of previous
studies1, which showed that an increase in the quantity of transfected GR plasmid
caused an increase in Kd and Hill coefficient and attributed this to the increase in
GR concentration per cell.
The distribution relative to the whole population is shown in Figure 3.11 (C).
The number of cells expressing a low amount of GR increased with an increase in
plasmid DNA although no statistically significant difference was found. In terms of
cells expressing a medium amount of GR, the same trend was observed with statis-
tically significant increases in cell numbers from 40 to 400 ng DNA and from 400 to
4000 ng at 48 h as well as from 40 to 400 and 4000 ng at 72 h. The trend strength-
ened with high GR expressing cells where highly statistically significant increases in
cell numbers were found between 40 to 400 ng DNA transfected populations at 48
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Figure 3.11: GR expression after tranfection with increasing plas-
mid DNA over 120 h. COS-1 cells were transiently transfected with
40, 400 or 4000 ng eGFP-GR expressing plasmid and (A) expres-
sion, as a proxy for transfection, of this plasmid was monitored
every 24 h up to 120 h by FACS. eGFP-GR expressing cells were
further characterized as either low, medium or high expressing rep-
resented as (B) proportional to the total amount of transfected cells
and (C) relative to the total cell population. Results were analyzed
using one-way ANOVA followed by Dunnett’s multiple comparisons
test. Statistically significant differences are indicated by *, **, ***
for p<0.05, p<0.01 or p<0.001, respectively and “ns” where no
statistically significant difference was found.
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and 72 h. Therefore, the ratio of low, medium and highly transfected cells remained
constant in response to increased plasmid DNA, while the overall percentage of the
population transfected increased from 16.8% to 58.5% at 48 h. Additionally, the
numbers of low, medium and high cells were maximal at 48 h and when 4000 ng GR
plasmid DNA was used for transfection.
3.4.1 Cell sorting to create a homologous population
Transfection of GR plasmid resulted in a heterogeneous distribution of GR express-
ing cells, with cells expressing low, medium, high or no GR present simultaneously in
a population (Figure 3.11). This presented a challenge to model simulations as the
model could only simulate cells of a single GR concentration at a time. To resolve
this, cells were sorted into low, medium and high GR expressing populations using
FACS with the intent of generating homogeneous populations for 3H-Dex whole cell
binding experiments 24 h later. Harvesting a 10 cm plate of COS-1 cells transfected
48 h prior with 4000 ng plasmid DNA yielded 1.62×105, 1.06×105 4.24×105 cells of
low, medium and high GR, respectively. However, 24 h after replating, the cells had
not survived and/or adhered sufficiently to perform a whole cell binding experiment.
Additionally, 24 h after sorting and replating, cells were tested for transfection dis-
tribution and it was discovered that the transfection distribution had redistributed
to pre-sort levels.
3.5 Compartmental model
Generation of a homologous population of transfected cells was not possible at the
time, therefore an alternate strategy was required to accurately simulate whole cell
binding experiments on heterogeneously GR transfected populations. To this end,
a compartmental model of the GR dimerisation cycle capable of taking into account
the population distribution of transfected cells was formulated. This compartmen-
tal model was formulated using the same rate and stoichiometric equations as the
original model (Section 3.1) except that it contained three GR dimerisation cycles,
using the same kinetic rate constants but different GR concentrations. Therefore,
the compartmental model could concurrently simulate binding in three cell popula-
tions, each with a different concentration of GR. Thereafter, this binding would be
scaled to the relative proportion of the total population of each category of cells, as
described in Section 5.2.4.
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Compartmental model internal consistency
The compartmental model was tested for internal consistency in the same way as the
original model was in Section 3.1. Figure 3.12 shows that all reaction rates reached
zero and the concentrations of all GR species reached equilibrium when the model
was initiated with 20 nM ligand. Therefore, the stoichiometry of the compartmental
model, similarly to the original model, does not violate the law of conservation of
matter and shows that the reaction scheme is logically consistent.
Compartmental model can be reduced to the non-compartmental model
There was a possibility that the compartmental model contained additional factors
not found in the non-compartmental model. To investigate this, saturation binding
data was simulated using the compartmental model with 100% of cells in either
the low, medium or high compartments. This resulted in r2 values of 0.87, 0.99
and 0.93 for low, medium and high GR, respectively (Figure 3.13), identical to
the simulated saturation binding data generated by the non-compartmental model
at 53, 108 and 192 nM (Figure 3.4). This demonstrates that the compartmental
model reduces to the non-compartmental model when 100% of the transfected cells
are in a single GR transfection category.
Compartmental model-simulated shifts in Kd and Hill coefficient
The ability of the compartmental model to simulate shifts in Kd and Hill coef-
ficient with relation to a shift in GR concentration distribution was investigated
(Figure 3.14). To simplify the analysis, only the low and high GR compartments
were used in these simulations, which was sufficient to demonstrate the proof of
concept. The total GR was fixed to the number of GR molecules contained in the
population when 20% of the cells are medium transfected cells and the other 80%
are untransfected. Adjusting the distribution of GR so that more of the total GR is
concentrated in high GR cells resulted in a decrease in Kd from 22.3 to 18.2 nM and
additionally, at the minimally and maximally concentrated GR levels Kds of 29.0
and 14.6 nM, respectively. Furthermore, the same adjustments resulted in a shift
in Hill coefficient from 1.45 to 1.65 and 1.27 and 2 at the minimally and maximally
concentrated levels respectively. Therefore, the Kd and Hill coefficient of a satura-
tion binding experiment is able to shift in response to a change in the distribution
of GR in a population.
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Figure 3.12: The GR dimerisation cycle compartmental math-
ematical model is internally consistent. The model was initiated
with koff values of 52.3, 6.4, 83.0 and 211.5 min
-1 for reactions 1
to 4 respectively and their respective counterparts in the medium
and high compartments, a kon value of 1 nM
-1.min-1 for reactions
1 to 3 and 1 nM-2.min-1 for reaction 4, a GR concentrations of 54,
123 and 229 nM for the three compartments, a ligand concentration
of 20 nM and simulated until the concentrations of all GR species
reached equilibrium and all reaction rates reached zero. (A) All
reaction rates reach zero. (B) All GR species concentrations reach
equilibrium. A description of the abbreviations can be found in
Appendix D.
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Figure 3.13: The compartmental model reduces to non-
compartmental model when only a single compartment is used.
Saturation binding data was simulated with 100% of the trans-
fected cells as either low, medium or high GR cells. Experimental
data reproduced from Robertson et al.1.
Figure 3.14: Comparison of saturation binding simulations us-
ing the compartmental model over a range of GR ratios. Satura-
tion binding experiments were simulated using the compartmental
model with different ratios of low and high GR cells. Total GR,
calculated as if 20% of cell population were medium transfected
cells, was kept constant and distributed into low and high GR cells,
represented by solid lines. The blue dashed line represents a sim-
ulation with total GR distributed equally amongst all cells in the
population. The red dashed line represents a simulation with total
GR inside a single cell.
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3.5.1 System analysis using the compartmental GR dimeri-
sation model with populated variables
To analyze how the distribution of GR within a population affects ligand binding,
compartmental model simulations were compared to experimental data. Saturation
binding data was simulated at low, medium and high amounts of GR and with ratios
of 2:1:1, 1:2:1 and 1:1:2 of low, medium and high cells (Figure 3.15). The total GR
was calculated as if 20% of the population were either low, medium or high GR cells
and the other 80% were untransfected. When generated with a low amount of GR
(Figure 3.15 (A)) r2 values of 0.830, 0.827 and 0.820 were obtained for the fit to low
experimental data, 0.981, 0.981 and 0.979 for the fit to medium experimental data
and 0.917, 0.920 and 0.926 for the fit to high GR experimental data of 2:1:1, 1:2:1 and
1:1:2 cell distributions, respectively. The shift in Kd and Hill coefficient produced
by the compartmental model was not sufficient to emulate the shift in Kd and Hill
coefficient observed in the experimental data in Figure 3.5. Moreover, the degree of
the shift in saturation binding between the 2:1:1 and 1:1:2 GR distributions was not
as significant as between 100% low GR cells and 100% high GR cells in Figure 3.13.
The same goodness of fit was obtained when the simulations were performed with
medium (Figure 3.15 (B)) and high (Figure 3.15 (C)) total GR. This suggests
that the shift in Kd and Hill coefficient demonstrated with the non-compartmental
model, shown above in Section 3.2.5, was not a function of GR concentration per se
and instead may be due to a shift in the ratio of GR distribution.
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Figure 3.15: Comparison of saturation binding simulations using
the compartmental model over a range of GR ratios and concentra-
tions to experimental data. Simulated saturation binding data was
generated using the compartmental model at ratios of 2:1:1, 1:2:1
and 1:1:2 of low, medium and high GR cells. Simulations were
performed with total GR equivalent to 20% of the cell population
possessing (A) low, (B) medium and (C) high GR and the other
80% untransfected. Experimental data reproduced from Robertson
et al.1.
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Chapter 4
Discussion
4.1 Synopsis
To date, the GR dimerisation cycle (Figure 2.8) has not been studied by math-
ematical modelling and characterization of its constituent reactions with regards
to Dex binding is a novel outcome of this study. While topological aspects of nu-
clear receptor signal transduction have been modeled before166, the formulation of
a mathematical model of the dimerisation cycle and subsequent binding simulation
is unique to this project.
The Kd determined for ligand-independent dimerisation is approximately 13-fold
higher than the Kd for dimerisation of liganded GR. This indicates that the binding
of ligand to the GR causes a conformational change in the protein, which drastically
increases the affinity of the GR molecule for homodimerisation. Ligand-independent
dimerisation is distinguished from the other reactions in the GR dimerisation cycle
in that it reaches equilibrium without addition of ligand. This means that, regardless
of the forward and reverse reaction rates, this step of the GR activation pathway is
already completed when ligand is added, possibly speeding up the rate of GR activa-
tion at higher GR concentrations. Since the kinetics of unliganded GR dimerisation
could not be determined, it is difficult to comment on how the relationship between
association and dissociation rates might influence the rate of GR activation.
When comparing the Kds of reactions 1 and 4, 52.3 nM for ligand binding to
GR monomer and 211.5 nM2 for ligand binding to GR dimer, these would appear to
indicate that the ligand has a 4-fold higher affinity for the monomer than the dimer.
However, reaction 1 measures the affinity of a single ligand while reaction 4 measures
the affinity of two ligands binding to GR subunits. Alternatively, the Kd of reaction
4 could be described as the product of two sequential ligand binding reactions,
described in Section 3.1, and the 211.5 nM2 value can be compared to 2735.3 nM2
54
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i.e. the product of two reactions of ligand binding to GR monomer. Therefore,
the GR dimer has approximately 13-fold higher affinity for two ligand molecules
than two monomers have. This implies that dimerisation induces a conformational
change, which increases the affinity of the GR for ligand, whether this change occurs
before ligand binding, after a single ligand binds to the GR dimer or a combination
of these two is unclear.
Similar shifts in Kd and Hill coefficient are seen when GR concentration is
increased (Figure 3.6) as when the ratio of high to low GR cells is increased
(Figure 3.14). When concurrently increasing the total GR and the ratio of high
to low GR cells the expected outcome was that these effects would combine to give
a greater shift in Kd and Hill coefficient than either individually. However, Fig-
ure 3.15 shows that when simulations are run using the compartmental model with
these two factors adjusted together; no shift in Kd or Hill coefficient is found when
total GR is adjusted. Considering that all results are normalized to the total GR
in the population, this further implicates cellular GR concentration and not overall
population GR concentration as the causative factor of the shifts in Kd and Hill
coefficient.
4.1.1 Concentration-dependent shifts in Kd and Hill coeffi-
cient are inherent to dimerisation reactions
The alternate pathway of GR activation has been proposed as the mechanism by
which the concentration-dependent effects of GR on Kd and Hill coefficient are
actuated1. However, Figure 3.3 (B) shows that even in the absence of ligand-
independent dimers, Kd decreases and the Hill coefficient increases with GR con-
centration. The concentration-dependent effects of GR are present in both pathways
of GR activation and therefore are not specific to ligand-independent dimerisation.
Moreover, experiments in this study (Figure 3.10) as well as in literature1 using the
GRdim mutant, that is to say with dimerisation eliminated, showed that potency
and cooperativity did not increase with an increase in total GR. Therefore, ligand
binding to GR monomer is not sufficient to produce a GR concentration-dependent
shift in Kd and Hill coefficient. Considering that the classical pathway displays
this shift (Figure 3.3 (B)) and that it is not dependent on ligand binding to GR
monomer, the shift is most likely a factor of the GR dimerisation. Unfortunately,
this cannot be confirmed experimentally as no experimental system is available in
which the classical and alternate pathways are isolated.
Running the model to equilibrium over a range of GR concentrations and without
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ligand showed that the relative amount of the total GR as dimers increased and
monomers decreased as the GR concentration increased. The numbers of monomeric
GR molecules can be calculated by using the formula for Kd and the breakdown of
the GR population, as shown below:
Kd =
[GRmonomer]
2
[GRdimer]
[GRtotal] = [GRmonomer] + 2[GRdimer]
[GRmonomer] =
−Kd ±
√
Kd + 8Kd[GRtotal]
4
Using this, the proportion of the total GR in the population as monomers and
dimers in a GR population were calculated for GR from 10 nM to 100 µM, shown
in Figure 4.1. The percentage of GR in the population as dimers is under 10% at
10 nM GR and over 95% percentage at 100 µM GR. The Kd was constant at all GR
concentrations and the proportion of the total GR population as dimers increased
with GR concentration. Therefore, the number of pre-formed GR dimers increases
disproportionately to the number of GR monomers in the cell as the total number
of GRs are increased. The correlation between percentage of the GR population
as dimers and total GR concentration has been experimentally shown by Bledsoe
et al.116. However, Bledsoe showed this relationship with Dex-bound GR LBD and
obtained a Kd of 1.5 µM, indicating that while the LBD is able to form dimers, the
rest of the GR protein increases GR-Dex affinity by at least 1000-fold. This non-
linear relationship between GR concentration and percentage GR dimers is rooted in
the conversion of two GR monomers to a single dimer molecule. Therefore, the shift
in proportion of the population that forms ligand-independent dimers is a property
of dimerisation reactions in general and not specific to the GR.
Macromolecular reactions are depicted in a way that is a convenient compromise
between level of detail and ease of use. These reactions may involve any number
of conversions, sometimes atomic or larger, each with their own thermodynamic
properties but which are not consequential enough to warrant inclusion in the most
common model. Accordingly, many of these minor reactions are omitted from the
models used to described these interactions. When reactions are omitted, their
thermodynamic properties are absorbed into the apparent dissociation constant of
the entire pathway. Therefore, if a constituent reaction has been overlooked or is
unknown, the equation used to describe a reaction may be inaccurate. Expressing
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Figure 4.1: Percentage of ligand-independent dimers compared to
total GR concentration. The percentage of the total GR population
as GR monomers and dimers were calculated from 1 to 100000 nM
GR with the Kd for dimerisation kept constant at 83 nM.
the binding of Dex, other ligands, to GR as a single reaction as:
2L+ 2R⇀↽(RL)2
does not contain sufficient detail to accurately describe the relationship between
fractional occupancy of the GR and GR concentration when GR concentration is
varied too far from the experimental data used to populate the model. Instead,
expressing this reaction as the entire dimerisation cycle is necessary to capture
enough detail for binding in this system to be accurately predicted. The decrease
in Kd and increase in Hill coefficient with an increase in GR concentration is likely
embedded in the thermodynamics of the overlooked dimerisation reactions of GR-
Dex binding.
4.1.2 Concentration-dependent decrease in Kd is a function
of a decrease in koff
The GR concentration-dependent shift in Kd of GR-Dex binding found by Robert-
son et al.1 was replicated in this study, albeit with a different range of Kd values.
However, the question remained: is this shift as a result of an increased rate of ligand
binding to GR at higher concentrations or as a result of a reduction in the rate of
ligand dissociation? The results of this study show that the trend of kon of GR-Dex
binding is not influenced by GR concentration and that the koff decreases as GR con-
centration increases (Figure 3.10). Furthermore, the kon trend is preserved, while
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the koff is not, when dimerisation is abrogated with the GRdim mutant. Therefore,
the GR concentration-dependent decrease in Kd is a function of a decrease in koff .
Having established a correlation between dimerisation and residence time, we can
now speculate about the exact mechanism by which koff is decreased by an increase
is GR concentration. Dissociation of a ligand requires a physical path out of the
ligand binding pocket. This path could be occluded by the other GR molecule in the
dimer, or by disruption of co-factors as found in other studies116, greatly reducing
the likelihood of ligand escaping the binding pocket. Therefore, the rate of ligand
dissociation from the GR might decrease, which protects the ligand from degrada-
tion. However, if dimerisation per se caused occlusion of the ligand binding pocket,
this would reduce the ability of ligand to bind to ligand-independent GR dimers.
In this case, the conformation selection model141 predicts that the unliganded GR
dimers exists as a number of isoforms with a continuum of ligand binding affinity.
Alternatively, following the induced fit model of ligand binding142,143, dimerisation
could cause the receptor to undergo an isomerisation reaction where the conforma-
tion of the complementarity network in the ligand binding pocket adjusts in such a
way that the affinity for the ligand increases. In particular, helices 1, 3 and 5 of the
ligand binding pocket, amongst other protein structures, are involved in the dimeri-
sation interface, which alters their conformation around the bound ligand116. This
would explain why the classical model of GR-ligand binding also shows a shift in
Kd and Hill coefficient despite cooperativity being precluded by the lack of multiple
ligand binding sites at the moment of ligand binding. The shift in percentage of the
population towards GR dimers, shown in Figure 4.1, as an increase in GR would
lead to a greater number of molecules in the higher affinity state and therefore the
population would have a lower rate of dissociation.
4.1.3 Increasing transfection plasmid DNA does not cause
increase in protein concentration per transfected cell
The dynamics of transient transfection are likely an overlooked but subtly conse-
quential factor in many studies. The effect of increasing GR plasmid concentration
on gene transcription has been studied in the past181 with regards to titration and
squelching effects. However, the analysis was based on the flawed assumption that
increased plasmid DNA increases the GR concentration per transfected cell. In our
study, expression of a transiently transfected plasmid took 48 h to reach a plateau
and lasted up until 96 h (Figure 3.11), which is consistent with transient trans-
fection convention. This may be attributed primarily to cells eliminating plasmid
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DNA, as well as the influence of mitosis, which dilutes both plasmid concentration
per cell as well as the protein level. In this way, the highly transfected cells may
become the medium and lowly transfected cells of the next generation.
What is not well understood is how the distribution of protein expression changes
with regard to quantity of transfected DNA. When the quantity of plasmid DNA was
increased, the absolute number of cells expressing low, medium and high amounts of
GR increased, which is to be expected as the greater quantity of plasmid molecules
increases the probability of an individual cell being transfected. However, the rel-
ative proportion of the transfected cell population expressing low, medium or high
amounts of GR remained constant regardless of the amount of plasmid DNA in
the transfection. Therefore, the ratio of low, medium and highly transfected cells
remained constant in response to increased plasmid DNA, while the overall percent-
age of the population transfected increased (Figure 3.11). Since the saturation
binding studies in Robertson et al. and the model simulations in this study are
normalized to the total receptor concentration, increasing the number of transfected
cells in proportion to the total GR in the population should not affect shape of the
saturation binding curves. This appears to undermine the assumptions of this and
other studies1 in that the average concentration of GR in transfected COS-1 cells
does not appear to increase with an increase in plasmid quantity.
4.2 Critique
As with any research project, a number of the results and methodologies are sus-
ceptible to further refinement. The characterization of reactions 2 to 4 of the GR
dimerisation cycle has, the best of our knowledge, not been attempted by other
researchers and, as a result, the Kd values determined in this study cannot be com-
pared to the literature. The GR dimerisation model is capable of replicating GR
concentration-dependent shifts in Kd and Hill coefficient of Dex binding; however,
the replicated shifts do not fully match the magnitude of the shift found in the
experimental data. This discrepancy could be the result of various factors. This
study is particularly vulnerable to inaccuracies in the Kds of reactions 1 and 3 be-
cause fitting of reactions 2 and 4 made use of these values. Another possibility is
that there could be a critical aspect of the GR-ligand model which has not been
included. Additionally, unliganded GR has been shown to have a number of cellular
effects1,182–186 and it is conceivable that these cellular effects may influence the Dex-
GR binding and to a greater extent at higher GR levels. Finally, inaccuracies of the
experimental data set cannot be ruled out. Although there is much to be gained by
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resolving this discrepancy, it does not diminish the qualitative analysis of the GR
dimerisation cycle made using the model.
The binding experiments performed in Robertson et al.1 were reported at 20%
transfection efficiency for 40, 400 and 4000 ng GR plasmid DNA transfection. Per-
sonal communication with the authors revealed that transfection efficiency was de-
termined by fluorescent microscopy, a less accurate method compared to the FACS
method used in this study. In the Robertson study, it was assumed that the same
proportion of the population was susceptible to transfection and that these cells were
simply transfected with a greater number of plasmid, and therefore contained more
GR per transfected cell. Consequently, the authors calculated the GR concentra-
tion per transfected cell as 5× the GR concentration in the entire population, which
was determined by saturation binding. This assumption does not fit the findings
in Figure 3.11, which shows that transfection efficiency increased from 16.8% to
58.5% at 48 h as DNA quantity increased from 40 to 4000 ng.
The Kd of ligand binding to monomeric GR was determined using the GRdim
mutant, where it was assumed that dimerisation was completely abrogated. How-
ever, as mentioned in Section 2.2.4, evidence is emerging that GRdim does form
dimers to some extent. The abrogation of trans-activation only implies that conven-
tional, trans-activating dimers are not formed but does not preclude the formation
of non-conventional dimers, which likely have impaired DNA binding capability.
The formation of non-conventional dimers is substantiated in a protein association
study by Presman et al.162, which shows that the GRdim mutant does dimerise to a
similar degree as GRwt. In the context of the current study, the ability of GRdim to
dimerise confounds determination of the Kd for reaction 1. Following the hypothesis
above, namely that the shift in Kd and Hill coefficient is an inherent property of
dimerisation, any formation of dimers would lower the Kd determined for reaction
1. Therefore, the Kd determined in this project is likely lower than the actual value
for this reaction.
Both the ligand and DNA binding domains of the GRwt have sequences that
are involved in dimerisation116,187,188. The source of GRdim’s dimerisation defi-
cient properties is a point mutation in the D-loop of the DNA binding domain at
A458T160 and it is hypothesized that the residual dimerisation is a result of the
dimerisation sequences in the ligand binding domain. In contrast to this, GRmon
contains mutations in both the ligand and DNA binding domains and was shown
to be completely dimerisation deficient162. Being relatively new, GRmon has not
been characterized as well as GRdim, particularly with regard to ligand binding
properties, which, when considering GRmon’s mutation in the ligand binding do-
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main, could differ from those of GRdim and GRwt. Currently, the GRmon mutant
is only available for the mouse GR; however, considering the similarities between
mouse and human GR, they likely possess similar binding properties. Overall, this
GRmon mutant is likely a more accurate representation of dimerisation deficiency
than GRdim and populating reaction 1 of the GR dimerisation cycle model with the
Kd for Dex binding to GRmon could improve simulation accuracy.
The determination of Kd for ligand-independent dimerisation of GR required an
analysis of previously published FRET data1. The FRET data was generated using
single cell microscopy and, as with any single cell measurement, the data may be
distorted when population characteristics, such as the average COS-1 cell volume
and protein concentration, are applied. In terms of this study, the GR concentration
from Robertson et al.1 was used to calculate the Kd of ligand-independent dimeri-
sation. If the transfection efficiencies were higher than the reported value, which is
likely considering that transfection efficiency was 58.5% at 48 h for 4000 ng plasmid
DNA transfection, then GR concentration would be lower than assumed and, conse-
quently, the Kd of reaction 3 would be lower. Similarly, if the transfection efficiency
were lower than the reported value, the Kd would be higher as GR concentration
would be higher than assumed. This affects the model both directly, as a change
in Kd of reaction 3, as well as indirectly through the fitting of the Kds of reactions
2 and 4, which depends on the ratio of the Kds of reactions 1 and 3. Considering
the potential for introduction of error when working with single cells and average
population characteristics, the similarity of the calculated Kd for the low, medium
and high GR concentrations is remarkable with a spread of only 10 nM. This sug-
gests that the large number of well carried out FRET experiments provided a large
enough data set to overcome the potential error inherent to FRET experiments.
The fitting of koff of reactions 2 and 4 was particularly susceptible to the accuracy
of the experimental data. The Kd reported for GR-Dex binding of the experimental
data set used throughout this study1 was 49.1, 23.9 and 16.8 nM for low, medium
and high GR, respectively; however, the average Kd for GR-Dex binding reported
in the literature is 6 nM. Following the hypothesis that increasing GR concentration
causes an increase in potency, the relatively high Kd values reported for this data
may indicate that the GR concentrations used in that study were significantly lower
than expected.
The transfection of GR into COS-1 cells in this study produced a heteroge-
neously distributed GR protein expression within the transfected population. For
this reason, cell sorting was attempted; however, despite the efforts to counter the
deleterious effects of sorting on cell health and viability, the homogeneous cell pop-
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ulations did not survive long enough to perform a whole cell binding experiment.
Cell sorting is usually performed in microscopy studies where the cells can be viewed
immediately after sorting and cell survival is not a concern. Had the cell sorting
been successful, the accuracy of all data determined from population studies would
have been improved. This includes the saturation binding experiments from which
the Kd for ligand binding to GR monomer (reaction 1) was determined in addition
to the Kd values determined for reactions 2 and 4, which were fitted to saturation
binding data produced with a heterogeneous population.
In order to improve cell survival, the FACS method could be modified in the
following two ways. Firstly, the nozzle size could be increased from 70 to 100 µm as
this would reduce the physical strain on the cells as they are sorted189. Unfortunately
a 100 µm nozzle was not available at the time of this study. Secondly, the sheath
fluid could be replaced with supplemented Dulbecco’s modified Eagle’s medium
(DMEM) as the sheath fluid was deemed to be toxic and is added to the sorted
suspension mixture as each cell is sorted. However, this could potentially lead to
future contamination of the sorting apparatus.
There was a large amount of error in kon and koff values determined from the
whole cell binding time course (Figure 3.10). It is possible that this method is not
optimized for determination of kinetic parameters for highly potent binding reac-
tions, such as steroid-steroid receptor bindings. For example, the binding with the
40 nM incubation saturated after 1 h, which may have caused an inaccurate fit of
the kon and koff values. Incubations over longer periods of time, i.e. at lower concen-
trations of Dex, will produce a longer saturation binding curve, which may improve
the accuracy of the binding model. Finally, the popularity of the DEAE-dextran
transfection method has fallen since the advent of viral vectors. DEAE∗, choloro-
quin† and DMSO‡ have significant toxicity which can result in aberrant experimental
results.
4.3 Context
The findings of this study show that the GR ligand binding system is more sensitive
to changes in GR concentration than previously anticipated.
∗http://www.sciencelab.com/msds.php?msdsId=9923344
†http://www.sciencelab.com/msds.php?msdsId=9923444
‡http://www.sciencelab.com/msds.php?msdsId=9927347
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4.3.1 Medical applications
The sensitivity of the GC signal transduction system to GR concentration has im-
plications in the development of GC resistance, a major concern for chronic GC
users190. A primary mechanism of GC resistance is the downregulation of the
GR188,191, which following the findings in this study, will reduce the effects of GCs
both by reducing the number of receptors and by reducing the efficiency with which
ligand binds to the receptor. The inverse is true of conditions that upregulate GR;
the effects of GCs will increase disproportionately to the concentration of GR.
GCs are often administered therapeutically and residence time or t1/2 is an im-
portant consideration for therapeutic regimes. Binding of the GC to the GR and
subsequent dimerisation of the GR complex increases residence times and thereby
reduces the dissociation rate of GCs and protects them from degradation, inadver-
tently increasing drug potency. Therefore, systems with a higher GR concentration
will not only be activated by GCs at lower concentrations, they will be active for
longer periods of time. In this way, in addition to activating palindromic GREs,
dimerisation is responsible for increasing the length of time the ligand remains bound
to GR and thereby increases the activity of ligands. From this it can be concluded
that GR concentration influences ligand activity not only as a substrate but also as
a mechanism by which ligand removal is mitigated. In the process of optimizing of
drug residence time, a similar susceptibility of the Kd to alteration by manipulation
of koff has been found by other researchers
137–139. The findings in this study have
significant implications for therapeutic regimes both with regard to drug residence
time as well as to tissues and individuals with different levels of GR.
4.3.2 Research implications
This model should be eminently useful for research aimed at exploring the
concentration-dependent effects of GR on GC activity. Measuring the concentra-
tion of the different GR species in the GR dimerisation cycle is not always feasible
as it requires protein interaction methods such as FRET or Numbers and Brightness.
However, total GR concentration can be quantified with relative ease with 3H-Dex
competitive binding assays or quantitative Western blot to mention a few methods.
Although the concentration-dependent effects of GR have primarily been shown
with Dex, it is likely this this effect is present with other, less potent glucocorticoids
as well as in other steroid receptor systems. The Kd for ligand-independent dimeri-
sation of GR is particularly useful in that, unlike the other dissociation constants, it
is not specific for Dex and could be used in a GR dimerisation model for any agonist.
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Considering the similarities in activation mechanisms between steroid receptors, it
is likely that a similar analysis to the one in the current project could yield novel
findings in other steroid receptor research fields.
4.3.3 Future studies
Currently, the model simulates GR-Dex binding at equilibrium and, while analysis
at equilibrium has yielded significant insights, the utility of the model would be
greatly improved by upgrading it to be time dependent. In order to achieve this,
the kon and koff values of each reaction of the GR dimerisation cycle would have to
be determined. This could be accomplished in a similar manner as the parameters
of the equilibrium model were determined. The kon and koff values of at least two
reactions would have to be determined experimentally and the remaining values
could be fitted to the whole cell binding data in Figure 3.9.
Ideally, the model would be expanded to include the ancillary pathways of GR
activation and GC signal transduction. These would include modelling intracellular
dynamic distributions of GR with regard to ligand concentration, GR up- and down-
regulation as well as ligand removal. Modelling DNA binding of GR is crucial not
only for predicting transcriptional activation but also for simulating stability of the
GR-ligand complex. GR tetramers have been detected by Presman et al.179, which
challenges the paradigm of GR dimers being the end product of ligand binding and,
with a few additions, it is not difficult to conceive of modelling the GR oligomeriza-
tion cycle. Additionally, the GR dimerisation cycle is not specific to Dex and could
be extended to include other GCs. Furthermore, to truly model GC transcriptional
activity in vivo, the heterogeneity of GR distribution within tissues would have to
be defined. It is unclear whether this heterogeneity is found in the distribution of
proteins between the cells of a tissue in vivo and, as concentration can affect bind-
ing in a non-linear way, should be investigated. Finally, from a molecular biologist’s
point of view, the ultimate goal of this project would be to model GR transcriptional
outcomes from total GR and ligand concentrations.
4.4 Conclusion
The current project comprised a novel approach of simulating GR-GC binding, which
is considered a requisite step of GR activation. A major outcome was the formu-
lation of a mathematical model of the GR dimerisation and Dex binding cycle.
Significantly, this model captured the GR concentration-dependent shifts in Kd and
Hill coefficient when simulating GR-Dex saturation binding experiments, albeit not
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to the same extent as experimental data from literature1. Therefore, the decrease
in Kd and increase in Hill coefficient with an increase in GR concentration found
by Robertson et al.1 was confirmed in our model. Moreover, this effect was deter-
mined to be the result of the dimerisation reaction in the GR activation pathway.
Furthermore, this model is capable of simultaneously predicting GR-GC binding in
cells of different GR concentrations. Using a method developed in this study, the
specific binding of a population of cells can be scaled to relative distribution of GR
within that cell population.
The kinetic basis for the decrease in Kd for Dex-GR binding was determined as
a concentration-dependent decrease in koff , as kon remained nearly constant with a
change in GR concentration. This decrease in koff is eliminated when dimerisation
is abrogated and therefore the concentration-dependent shift in Kd is attributed to
the dimerisation reactions present in both the classical and alternate pathways of
GR activation.
The findings demonstrate that GC-GR binding is more sensitive to GR con-
centration than has been previously anticipated. Considering the similarities in
activation mechanisms between steroids and steroid receptors, it is likely that a
similar analysis to the one in this project could yield novel findings in other steroid
receptor research fields. This has implications for GC signal transduction research,
steroid research in general as well as for therapeutic regimes and GR resistance
development.
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Chapter 5
Methods and materials
5.1 Experimental methods and materials
Plastic-ware was obtained from reputable suppliers of laboratory equipment such of
WhiteSci, Lasec, The Scientific Group and Biocom.
5.1.1 Cell culture
COS-1 cells were obtained from American Type Culture Collection and were cul-
tured in DMEM containing 44 mM sodium bicarbonate and 1 mM sodium pyruvate
purchased from Sigma-Aldrich (St. Louis, Missouri, United States). In addition,
supplemented DMEM contained 10% Fetal Bovine Serum (FBS), 100 IU/ml of peni-
cillin, 100 µg/ml of streptomycin purchased from Merck (Darmstadt, Germany).
Cultures used ranged from passage 6 to 35.
5.1.2 Plasmids
The human GRwt plasmid, pEGFP-C2-hGRwt, was provided by S. Okret (Karolin-
ska Institute, Sweden). Human GRdim plasmid, pEGFP-C2-hGRdim, was produced
by Steven Robertson (Stellenbosch University, South Africa) by replacing the wild
type GR in pEGFP-C2-hGRwt with dimerisation deficient GRdim. The empty
vector, PGL2-Basic, was obtained from Promega. Plasmids were harvested using
the NucleoBond®Xtra Maxi plasmid extraction kit as per manufacturers instruc-
tions. Plasmid identity was confirmed by restriction enzyme digest with Sal1 for
pEGFP-C2-hGRwt and pEGFP-C2-hGRdim from Thermo Fischer and BamH1 for
PGL2-Basic from Fermentas.
66
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5.1.3 3H-Dexamethasone whole cell binding
COS-1 cells, transfected 24 h prior, as described below, with 40, 400 or 4000 ng of
either pEGFP-C2-hGRwt or pEGFP-C2-hGRdim, were plated into 24 well plates
at a density of 0.5×105 cells/well 24 h prior to steroid incubation. On the day of
incubation, plasmid expression and distribution was tested by means of FACS, as
described below. After expression confirmation, cells were washed three times with
Phosphate Buffered Saline (PBS) and subsequently incubated with 250 µl DMEM
containing either 20 or 40 nM tritiated Dexamethasone (3H-Dex) (PerkinElmer SA
(Pty) Ltd), stock specific activity ranging from 71 to 78 Ci/mmol, for up to 4 h. Non-
specific binding was determined by concomitant incubation of 10 µM Dex with either
of the aforementioned concentrations of 3H-Dex at each time point. The incubation
was concluded by aspiration and cells were subsequently washed with 0.2% Bovine
Serum Albumin (BSA) in PBS at 4°C three times for 15 min. Thereafter, the cells
were lysed with 100 µl passive lysis buffer (0.2% (v/v) Triton, 10% (v/v) glycerol,
2.8% (v/v) TRIS-phosphate-EDTA and 1.44 mM EDTA) and stored at -20°C until
scintillation counting. Scintillation counting was performed as described below and
counts were normalised to protein concentration determined using the Bradford
method192.
Transfection
The DEAE-dextran transfection method193 was used in this study. COS-1 cells
were plated in 10 cm plates at 106 cells/plate 24 h before transfection. Cells were
incubated in a transfection mixture containing DMEM with 1% diethylaminoethyl
(DEAE) (Sigma-Aldrich), 0.1% chloroquinone and 4000 ng total plasmid DNA for
4 h. Different levels of GR expression were induced by adding either 40, 400 or
4000 ng of pEGFP-C2-hGRwt or pEGFP-C2-hGRdim. Total plasmid DNA was
kept constant at 4000 ng by adding the non-expressing plasmid, PGL2-Basic, to
compensate for the different quantities of expression plasmid DNA. Following the
4 h incubation, the transfection mixture was replaced and the cells were incubated in
5 ml 10% dimethyl sulfoxide (DMSO) (Sigma-Aldrich) PBS for 5 min. Thereafter,
the DMSO was replaced with supplemented DMEM.
Transfection efficiency
Transfection efficiency was tested using the BD FACSAria system by making use
of the prosthetic eGFP of the GRwt and GRdim proteins. 24 h after transfection,
2 × 105 cells/well were plated into a 6 well plate and 24 h later were harvested for
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flow cytometry. Fluorescein isothiocyanate (FITC) BD-Calibrite 3 beads (BD Bio-
sciences, San Jose) were used as an internal standard. Transfected cells were deter-
mined as those with a FITC-A value of over 102.5 using a 488 nm laser. Transfected
cells were further categorized as low transfected, with a FITC-A range 102.5 to 103.3,
moderately transfected, with a FITC-A range 103.3 to 104.2, or highly transfected,
with a FITC-A range 104.2 or higher. An example of this is given in Appendix E.
Scintillation counting
Liquid scintillation counting was used to measure the amount of 3H-Dex bound
to GR in the cell lysate. Scintillation was measured using a Tri-Carb 2810TR
(PerkinElmer) in Pony vials (PerkinElmer). The scintillation mixture contained
80 µl of cell lysate and 1 ml of FLO Scint II scintillation fluid (PerkinElmer). Ligand
depletion was calculated using a control counted with 5 µl of 20 or 40 nM 3H-Dex
and was always <5%.
Protein determination
Protein concentration of each sample was determined by the Bradford method of
protein determination192 using a Powerwave 340 Biotek to measure absorbance at
595 nM. The sample solution contained 5 µl cell lysate and 200 µl Bradford reagent
and was incubated for 30 min before absorbance was determined. Protein con-
centration was calculated by comparing samples to a BSA standard curve, BSA
concentration ranging from 0 to 2 mg/ml, after normalisation to a blank sample.
Determination of kinetic parameters
The forward and reverse reactions occur simultaneously and consequently cannot
be determined from a single binding time course. Whole cell binding time courses
were conducted at two concentrations of 3H-Dex so that the reaction rate constants
could be solved simultaneously using the model below194:
Kd =
koff
kon
kob = konL+ koff
occupancy =
L
Kd + L
Ymax = occupancy ×Bmax
Y = Ymax(1− e−kobX)
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where Y is non-specific binding, X is time in minutes, L is the ligand concentra-
tion, Bmax is the maximum binding at equilibrium, kob is the observed reaction
rate constant and kon and koff are the forward and reverse reaction rate constants,
respectively.
Cell sorting
In an attempt to produce a homogeneously GR expressing population, FACS was
incorporated into the whole cell binding experimental design. COS-1 cells were
transfected as described above, 48 h later the cells were harvested by trypsinisation,
washing cells off of a containment vessel following 5 min incubation in trypsin-
Ethylenediaminetetraacetic acid (Merck), centrifuged at 2000 rpm for 5 min, the
supernatant was aspirated, the cells were resuspended in PBS and sorted using the
BD FACSAria according to the eGFP-GR expression categories described in Sec-
tion 5.1.3. The sorted cells were centrifuged at 2000 rpm for 5 min, the supernatant
was aspirated, the cells were resuspended in supplemented DMEM and plated into
24 well plates at a density of 0.5× 105 cells/well 24 h prior to whole cell time course
binding as described above. Sorting cells for the purposes of performing a whole cell
binding experiment 24 h later is a novel approach and a number of challenges were
encountered.
The cell yield obtained from sorting a transfected 10 cm plate was relatively
low when compared to the number of cells required to perform a whole cell binding
experiment. The number of transfected 10 cm plates required to generate enough
sorted cells would be burdensome to produce and the time required to sort such
a large number of cells was not suitable for the experimental design. This issue
was resolved by changing the experimental design from plating out only sorted cells
for the whole cell binding experiment to plating out a mixture containing 10%
sorted transfected cells and 90% unsorted untransfected cells. Unsorted cells were
harvested by trypsinisation immediately after sorting of the tranfected cells. The
untransfected cells would not influence the whole cell binding as they did not contain
GR and therefore could not contribute to specific binding. This reduced the number
of cells required for harvesting by 10-fold without influencing the results.
The sorted COS-1 cells did not survive and/or adhere to cell culture plates
for 24 h after harvesting and sorting. A number of avenues were explored to try
improve the survival and adherence of the cells. First, the pre-sort suspension which
contained the cells prior to sorting was changed from PBS to 1% FCS PBS with
the justification that this would reduce the harm to the cells in the period between
harvesting and sorting. Second, the post-sort medium was changed from 10% FCS
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DMEM to 20% FCS DMEM with the justification that this medium is diluted
by a factor of 2 during sorting as cells are sorted with a small volume of sheath
fluid. Third, the sort speed was reduced from 1000 cells per second to 200 with the
justification that the high rate of sorting was causing strain on the cells when they
expanded after leaving the nozzle.
5.1.4 Transfection efficiency trial
COS-1 cells were plated into 5× 6 well plates at a density of 2× 105 cells/well 24 h
prior to transfection. Wells of each plate were transfected as described above such
that each plate contained a low, medium and high transfected and an untransfected
well. At times of 24, 48, 72, 96 and 120 h a plate was harvested by trypsinisation
and resuspended in PBS before transfection efficiency and distribution was tested
using the BD FACSAria system as described above.
5.2 Computational and modelling methods
Modelling and computational analyses were performed within an IPython195
notebook using the Python196 programming language with extensive use of the
PySCeS178, NumPy197, SciPy198 and Matplotlib199 packages.
5.2.1 Model construction
The model for GR dimerisation and ligand binding was constructed from the classical
and alternate pathways: Ligand binding to GR and subsequent GR-ligand complex
homodimerisation and GR homodimerisation followed by binding of two ligands
respectively. Classical rate and stoichiometric reactions were used to construct an
internally consistent model in compliance with the PySCeS “.psc” file format, shown
in Appendix A. Additionally, models were constructed containing only the classical
and alternate activation pathways, shown in Appendix B and C, respectively.
Simulating whole cell GR 3H-Dex saturation binding curves
In terms of radiolabelled binding assays, specific binding represents the binding of
the radiolabelled ligand to the specific protein of interest and is calculated:
Bs = Bt −Bns
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where Bt, Bs and Bns are total, specific and non-specific binding, respectively. Total
binding was measured after incubation with the 3H-Dex. Non-specific binding was
measured after incubation with a competitor to the 3H-Dex, in this case, a molar
excess of non-tritiated Dex.
The model was used to simulate GR 3H-Dex whole cell saturation binding curves.
The model was initiated with a ligand concentration of 20 nM and a GR concentra-
tion of 54, 123 or 229 nM representing either low, medium or high GR, respectively
as described by Robertson et al.1 and run to equilibrium. The equilibrium con-
centration values for RL, ligand bound GR, and RLRL were recorded and specific
binding was calculated:
Bs = RL+ 2×RLRL
where RL is ligand bound receptor monomer and RLRL is liganded receptor dimer.
The liganded dimer is multiplied by two as there are two ligands bound per molecule.
This is performed at a range of ligand concentrations and specific binding was cal-
culated and recorded each time. The specific binding at each ligand concentration
was scaled to the specific binding at the maximum ligand concentration.
Bsc =
Bs
Bms
× 100
where Bms represents the maximum specific binding and Bsc represents the scaled
specific binding. The resulting scaled specific bindings were plotted against ligand
concentrations and were analogous to experimentally generated whole cell binding
GR 3H-Dex saturation binding curves.
5.2.2 Calculating ligand independent dimerisation
The data used to calculate ligand independent dimerisation was obtained from pub-
lished FRET experiments1. This data shows homodimerisation of GR in the unli-
ganded and liganded states at different concentrations of GR and therefore could be
used to calculate the dissociation constant for ligand independent dimerisation of
the GR. Total GR concentration was determined by whole cell 3H-Dex saturation
binding. The transfection efficiency reported for this data was 20%, therefore the
concentration per transfected cell was 5× higher than that of the average cell. This
was compensated for in the calculation by scaling up the GR concentration by a
factor of 5 which had the effect of increasing the Kd 5-fold. Total CFP-GR and
YFP-GR concentrations were calculated as half the total GR concentration and the
maximum possible CFP-GR-YFP-GR heterodimer concentration was calculated as
a third of this, using the population breakdown determined by Robertson et al.1.
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The FRET signal after 30 min of Dex induction was taken as the maximum FRET
signal, i.e. the signal at 100% GR dimerisation, while the FRET signal at t=0
was taken to represent the basal level of unliganded GR dimerisation. The ratio of
non-Dex induced FRET signal to maximally induced signal was multiplied by the
maximum CFP- and YFP- GR heterodimer concentration which was taken to rep-
resent the concentration of heterodimer in the unliganded state. Monomeric CFP-
and YFP- GR were calculated using the CFP-YFP GR heterodimer concentration
and total the CFP-GR and YFP-GR concentrations as well as the model for de-
termining the concentrations of monomeric CFP- and YFP- GR from FRET time
course data, shown below, developed by Robertson et al.1.
C = ((3× C2) + 2× C × CY − (CY )2)/(C + CY )
where C represents monomeric CFP- or YFP- GR concentration and CY represents
heterodimer concentration.
The % GR monomers, shown in Table 3.2 was calculated by taking the ratio
of CFP-GR or YFP-GR without Dex stimulation, found in Table 3.1 to the total
CFP-GR or YFP-GR. The % GR dimers was calculated from % GR monomers as:
%GRdimers = 100−%GRmonomers
The Kd of reaction 3, ligand independent GR dimerisation, was calculated from
concentrations of unliganded monomer and dimer using the mass action form of the
dissociation constant calculation:
Kd =
[GRmonomers]
2
[GRdimers]
5.2.3 Fitting the dissociation constants
The dissociation constants for dimerisation of liganded GR monomers and ligand
binding to unliganded GR dimers were obtained by fitting the GR dimerisation cycle
model consisting of the reaction shown above to experimental data using the mini-
mize method of the LmFit Python package200. This experimental data was obtained
from 3H-Dex saturation binding experiments performed in COS-1 cells transiently
transfected with differing amounts of GRwt and GRdim containing plasmids and
published previously1.
The fitting procedure was as follows: a value for the dissociation constant for
dimerisation of liganded GR monomers was estimated, using this, and the thermody-
namic relationship within the dimerisation cycle, a dissociation constant for ligand
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binding to unliganded GR dimers was calculated. The value for GR concentration
in the model was set to match one of the data sets from the experimental data. Us-
ing the PySCeS package, a parameter scan on ligand concentration was performed
and liganded monomer and dimer concentrations were returned. These values were
used to calculate specific binding over a range of ligand concentrations, effectively
generating a saturation binding curve. The residuals were calculated by subtracting
the model generated saturation binding curve, at each concentration of GR, from
the experimental data. The residuals were then returned and the process repeated
until the dissociation constant for dimerisation of liganded GR which results in the
smallest residuals is estimated.
5.2.4 Compartmental model formulation
A compartmental model was generated which contained three replicates of the GR
dimerisation cycle, shown in Appendix D.
Calculating cell number from fixed glucocorticoid receptor amount
The average amount of GR per cell for low, medium and high cells was determined by
Robertson1. Using this, the ratio of GR in a low GR cell to that in low, medium and
high GR cells is calculated. The distribution between low, medium and high cells
is determined by flow cytometry. From these, the fraction of the total GR in each
population group is determined. Using this fraction, the total GR is divided into
total GR molecules in each cell type. Once again using the GR concentration in low,
medium and high cells together with the average COS-1 cell protein concentration
and Avogadro’s number, the number of low, medium and high cells are calculated.
Finally, the specific binding was calculated similarly to the single compartment
model, described in Section 5.2.1, and scaled to the relative cell numbers of the
different compartments and compared to experimental data. An example of this
distribution is given below:
Global variables:
NAvogadro = 6.02× 1023 molecules per mol
ProteinCOS−1 = 6.49× 10−7mg/cell
NTransfected cells = 2× 105 cells
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Method variables as example:
FractionLow = 0.5
FractionMedium = 0.25
FractionHigh = 0.25
GR proteinLow = 335× 10−15fmol GR/mg protein
GR proteinMedium = 763× 10−15fmol GR/mg protein
GR proteinHigh = 1420× 10−15fmol GR/mg protein
GR moleculesTotal = NTransfected cells × ProteinCOS−1 ×NAvogadro ×GR proteinMedium
= 2× 105 × 6.49× 10−7 × 6.02× 1023 × 763× 10−15
= 59.6× 109 molecules
The ratio of GR in low, medium and high cells to low cells:
GR ratioLow = GR proteinLow/GR proteinLow
= (335× 10−15)/(335× 10−15)
= 1
GR ratioMedium = GR proteinMedium/GR proteinLow
= (763× 10−15)/(335× 10−15)
= 2.27
GR ratioHigh = GR proteinHigh/GR proteinLow
= (1420× 10−15)/(335× 10−15)
= 4.24
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Finding the fraction of the total GR in each population group:
RelativeLow = GR ratioLow × FractionLow
= 1× 0.5
= 0.5
RelativeMedium = GR ratioMedium × FractionMedium
= 2.27× 0.25
= 0.57
RelativeHigh = GR ratioHigh × FractionHigh
= 4.24× 0.25
= 1.06
RelativeDenominator = RelativeLow + RelativeMedium + RelativeHigh
= 0.5 + 0.57 + 1.06
= 2.13
Calculating the amount of GR in each population based on fractions above:
NGR in low cells = GR moleculesTotal × RelativeLow/RelativeDenominator
= 59.6× 109 × 0.5/2.13
= 14× 109 GR molecules
NGR in medium cells = GR moleculesTotal × RelativeMedium/RelativeDenominator
= 59.6× 109 × 0.57/2.13
= 16× 109 GR molecules
NGR in high cells = GR moleculesTotal × RelativeHigh/RelativeDenominator
= 59.6× 109 × 1.06/2.13
= 30× 109 GR molecules
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Calculating the number of low, medium and high cells:
NLow GR cells = NGR in low cells/(GR proteinLow × ProteinCOS−1 ×NAvogadro)
= 14× 109/(335× 10−15 × 6.49× 10−7 × 6.02× 1023)
= 1.06965× 105 cells
NMedium GR cells = NGR in medium cells/(GR proteinMedium × ProteinCOS−1 ×NAvogadro)
= 16× 109/(763× 10−15 × 6.49× 10−7 × 6.02× 1023)
= 0.53673× 105 cells
NHigh GR cells = NGR in high cells/(GR proteinHigh × ProteinCOS−1 ×NAvogadro)
= 30× 109/(1420× 10−15 × 6.49× 10−7 × 6.02× 1023)
= 0.54074× 105 cells
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Appendix A
Glucocorticoid receptor dimerisation cycle model
The Glucocorticoid receptor dimerisation cycle model “.psc” file. R1, represents reac-
tion 1, ligand binding to monomeric GR; R2, represents reaction 2, homodimerisation of
liganded GR; R3, represents reaction 3, homodimerisation of unliganded GR; and R4,
represents reaction 4, binding of two ligands to unliganded GR homodimer. L represents
the ligand Dex and is fixed as Dex is present in excess in the experiments therefore lig-
and depletion did not occur. R represents the monomeric unliganded GR, RL represents
liganded monomeric GR, RLRL represents liganded GR homodimer and RR represents
unliganded GR homodimer. k1 to k4 and k 1 to k 4 represent the forward and reverse
reaction rate constants of reactions 1 to 4, respectively.
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## Glucocorticoid receptor dimerisation cycle model .psc file
# Concentrations in nM
# Time units in minutes
FIX: L
R1:
R + L = RL
R * L * k1 - RL * k_1
R2:
{2}RL = RLRL
RL**2 * k2 - RLRL * k_2
R3:
{2}R = RR
R**2 * k3 - RR * k_3
R4:
RR + {2}L = RLRL
RR * L**2 * k4 - RLRL * k_4
#InitEx
L = 20
#InitPar
k1 = 1
k_1 = 52.3
k2 = 1
k_2 = 6.4
k3 = 1
k_3 = 83.0
k4 = 1
k_4 = 211.5
#InitVar
R = 54
RL = 0
RR = 0
RLRL = 0
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Appendix B
Glucocorticoid receptor classical activation path-
way model
The Glucocorticoid receptor dimerisation cycle model “.psc” file. R1, represents reaction
1, ligand binding to monomeric GR and R2, represents reaction 2, homodimerisation of
liganded GR. L represents the ligand Dex and is fixed as Dex is present in excess in
the experiments therefore ligand depletion did not occur. R represents the monomeric
unliganded GR, RL represents liganded monomeric GR and RLRL represents liganded
GR homodimer. k1 and k2 and k 1 and k 2 represent the forward and reverse reaction
rate constants of reaction 1 and 2, respectively.
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## Glucocorticoid receptor classical activation pathway model .psc file
# Concentrations in nM
# Time units in minutes
FIX: L
R1:
R + L = RL
R * L * k1 - RL * k_1
R2:
{2}RL = RLRL
RL**2 * k2 - RLRL * k_2
#InitEx
L = 20
#InitPar
k1 = 1
k_1 = 52.3
k2 = 1
k_2 = 6.4
#InitVar
R = 54
RL = 0
RLRL = 0
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Appendix C
Glucocorticoid receptor alternate activation path-
way model
The Glucocorticoid receptor dimerisation cycle model “.psc” file. R1, represents reaction 1,
homodimerisation of unliganded GR and R2, represents reaction 2, binding of two ligands
to unliganded GR homodimer. L represents the ligand Dex and is fixed as Dex is present
in excess in the experiments therefore ligand depletion did not occur. R represents the
monomeric unliganded GR, RLRL represents liganded GR homodimer and RR represents
unliganded GR homodimer. k1 and k2 and k 1 and k 2 represent the forward and reverse
reaction rate constants of reaction 1 and 2, respectively.
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## Glucocorticoid receptor alternative activation pathway model .psc file
# Concentrations in nM
# Time units in minutes
FIX: L
R1:
{2}R = RR
R**2 * k1 - RR * k_1
R2:
RR + {2}L = RLRL
RR * L**2 * k2 - RLRL * k_2
#InitEx
L = 20
#InitPar
k1 = 1
k_1 = 83.0 # got from the % dimerisation data in paper (corrected x5)
k2 = 1
k_2 = 211.5 # fitted from GRwt Low
#InitVar
R = 54
RR = 0
RLRL = 0
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Appendix D
Glucocorticoid receptor dimerisation cycle com-
partmental model
The glucocorticoid receptor dimerisation cycle compartmental model “.psc” file. R1, rep-
resents reaction 1, ligand binding to monomeric GR in the low GR compartment; R2,
represents reaction 2, homodimerisation of liganded GR in the low GR compartment; R3,
represents reaction 3, homodimerisation of unliganded GR in the low GR compartment;
and R4, represents reaction 4, binding of two ligands to unliganded GR homodimer in the
low GR compartment. Reactions 5 to 8 correspond to reactions 1 to 4 respectively with
the exception that they relate to the medium GR compartment. Reactions 9 to 12 corre-
spond to reactions 1 to 4 respectively with the exception that they relate to the high GR
compartment. L represents the ligand Dex and is fixed as Dex is present in excess in the
experiments therefore ligand depletion did not occur. Rlow, Rmed and Rhigh represents
the monomeric unliganded GR in the low, medium and high GR compartments, respec-
tively; RLlow, RLmed and RLhigh represents liganded monomeric GR in the low, medium
and high GR compartments, respectively; RLlowRLlow, RLmedRLmed and RLhighRL-
high represents liganded GR homodimer in the low, medium and high GR compartments,
respectively; and RlowRlow, RmedRmed and RhighRhigh represents unliganded GR ho-
modimer in the low, medium and high GR compartments, respectively. k1 to k4 and k 1
to k 4 represent the respective forward and reverse reaction rate constants of reactions 1
to 4, 5 to 8 and 9 to 12.
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## Glucocorticoid receptor dimerisation cycle compartmental model .psc file
# Concentrations in nM
# Time units in minutes
FIX: L
# Low GR population
R1:
Rlow + L = Rlow_L
Rlow * L * k1 - Rlow_L * k_1
R2:
{2}Rlow_L = Rlow_LRlow_L
Rlow_L**2 * k2 - Rlow_LRlow_L * k_2
R3:
{2}Rlow = RlowRlow
Rlow**2 * k3 - RlowRlow * k_3
R4:
RlowRlow + {2}L = Rlow_LRlow_L
RlowRlow * L**2 * k4 - Rlow_LRlow_L * k_4
# Medium GR population
R5:
Rmed + L = Rmed_L
Rmed * L * k1 - Rmed_L * k_1
R6:
{2}Rmed_L = Rmed_LRmed_L
Rmed_L**2 * k2 - Rmed_LRmed_L * k_2
R7:
{2}Rmed = RmedRmed
Rmed**2 * k3 - RmedRmed * k_3
R8:
RmedRmed + {2}L = Rmed_LRmed_L
RmedRmed * L**2 * k4 - Rmed_LRmed_L * k_4
# High GR population
R9:
Rhigh + L = Rhigh_L
Rhigh * L * k1 - Rhigh_L * k_1
R10:
{2}Rhigh_L = Rhigh_LRhigh_L
Rhigh_L**2 * k2 - Rhigh_LRhigh_L * k_2
R11:
{2}Rhigh = RhighRhigh
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Rhigh**2 * k3 - RhighRhigh * k_3
R12:
RhighRhigh + {2}L = Rhigh_LRhigh_L
RhighRhigh * L**2 * k4 - Rhigh_LRhigh_L * k_4
#InitEx
L = 20
#InitPar
k1 = 1
k_1 = 52.3
k2 = 1
k_2 = 6.4
k3 = 1
k_3 = 83.0
k4 = 1
k_4 = 211.5
#InitVar
Rlow = 54
Rlow_L = 0
RlowRlow = 0
Rlow_LRlow_L = 0
Rmed = 123
Rmed_L = 0
RmedRmed = 0
Rmed_LRmed_L = 0
Rhigh = 229
Rhigh_L = 0
RhighRhigh = 0
Rhigh_LRhigh_L = 0
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Appendix E
An example of FACS determination of transfection efficiency and distribution, as described
in Section 5.1.3.
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